Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 543 articles:
HTML format
Text format



Single Articles


    January 2018
  1. KONDILI LA, Gaeta GB, Ieluzzi D, Zignego AL, et al
    Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.
    PLoS One. 2018;13:e0190803.
    PubMed     Text format     Abstract available


  2. CHARRE C, Cotte L, Kramer R, Miailhes P, et al
    Hepatitis C virus spread from HIV-positive to HIV-negative men who have sex with men.
    PLoS One. 2018;13:e0190340.
    PubMed     Text format     Abstract available


  3. CHEN SH, Lai HC, Chiang IP, Su WP, et al
    Changes in liver stiffness measurement using acoustic radiation force impulse elastography after antiviral therapy in patients with chronic hepatitis C.
    PLoS One. 2018;13:e0190455.
    PubMed     Text format     Abstract available


  4. LEE CS, Jung YJ, Kim SS, Cheong JY, et al
    Liver volume-based prediction model stratifies risks for hepatocellular carcinoma in chronic hepatitis B patients on surveillance.
    PLoS One. 2018;13:e0190261.
    PubMed     Text format     Abstract available


  5. CARIMO AA, Gudo ES, Maueia C, Mabunda N, et al
    First report of occult hepatitis B infection among ART naive HIV seropositive individuals in Maputo, Mozambique.
    PLoS One. 2018;13:e0190775.
    PubMed     Text format     Abstract available


  6. BIVIGOU-MBOUMBA B, Amougou-Atsama M, Zoa-Assoumou S, M'boyis Kamdem H, et al
    Hepatitis B infection among HIV infected individuals in Gabon: Occult hepatitis B enhances HBV DNA prevalence.
    PLoS One. 2018;13:e0190592.
    PubMed     Text format     Abstract available


  7. FARSHADPOUR F, Taherkhani R, Ravanbod MR, Eghbali SS, et al
    Prevalence, risk factors and molecular evaluation of hepatitis E virus infection among pregnant women resident in the northern shores of Persian Gulf, Iran.
    PLoS One. 2018;13:e0191090.
    PubMed     Text format     Abstract available


  8. LEE HJ, Kim SJ, Kweon YO, Park SY, et al
    Evaluating the efficacy of switching from lamivudine plus adefovir to tenofovir disoproxil fumarate monotherapy in lamivudine-resistant stable hepatitis B patients.
    PLoS One. 2018;13:e0190581.
    PubMed     Text format     Abstract available


  9. MAROT A, Dubois M, Trepo E, Moreno C, et al
    Liver transplantation for alcoholic hepatitis: A systematic review with meta-analysis.
    PLoS One. 2018;13:e0190823.
    PubMed     Text format     Abstract available


  10. OBIRI-YEBOAH D, Asante Awuku Y, Adu J, Pappoe F, et al
    Sero-prevalence and risk factors for hepatitis E virus infection among pregnant women in the Cape Coast Metropolis, Ghana.
    PLoS One. 2018;13:e0191685.
    PubMed     Text format     Abstract available


  11. HEIL J, Hoebe CJPA, Loo IHMV, Cals JWL, et al
    Hepatitis E prevalence in a sexual high-risk population compared to the general population.
    PLoS One. 2018;13:e0191798.
    PubMed     Text format     Abstract available


  12. BOLOTIN S, Feld JJ, Garber G, Wong WWL, et al
    Population-based estimate of hepatitis C virus prevalence in Ontario, Canada.
    PLoS One. 2018;13:e0191184.
    PubMed     Text format     Abstract available


  13. CHENG CH, Lin CC, Chen HL, Lin IT, et al
    Genotype distribution and treatment response among incarcerated drug-dependent patients with chronic hepatitis C infection.
    PLoS One. 2018;13:e0191799.
    PubMed     Text format     Abstract available


  14. DEL CAMPO JA, Garcia-Valdecasas M, Gil-Gomez A, Rojas A, et al
    Simvastatin and metformin inhibit cell growth in hepatitis C virus infected cells via mTOR increasing PTEN and autophagy.
    PLoS One. 2018;13:e0191805.
    PubMed     Text format     Abstract available


  15. NDJOYI-MBIGUINO A, Kombe Kombe AJ, Bivigou-Mboumba B, Zoa-Assoumou S, et al
    Low prevalence of HCV infection with predominance of genotype 4 among HIV patients living in Libreville, Gabon.
    PLoS One. 2018;13:e0190529.
    PubMed     Text format     Abstract available


  16. SAFREED-HARMON K, Hetherington KL, Aleman S, Alho H, et al
    Policy responses to hepatitis C in the Nordic countries: Gaps and discrepant reporting in the Hep-Nordic study.
    PLoS One. 2018;13:e0190146.
    PubMed     Text format     Abstract available


  17. ZAHR NM
    Peripheral TNFalpha elevations in abstinent alcoholics are associated with hepatitis C infection.
    PLoS One. 2018;13:e0191586.
    PubMed     Text format     Abstract available


  18. DE PINA-ARAUJO IIM, Spitz N, Soares CC, Niel C, et al
    Hepatitis B virus genotypes A1, A2 and E in Cape Verde: Unequal distribution through the islands and association with human flows.
    PLoS One. 2018;13:e0192595.
    PubMed     Text format     Abstract available


  19. HUGHES E, Hopkins LJ, Parker R
    Survival from alcoholic hepatitis has not improved over time.
    PLoS One. 2018;13:e0192393.
    PubMed     Text format     Abstract available


  20. KELLY ML, Riordan SM, Bopage R, Lloyd AR, et al
    Capacity of non-invasive hepatic fibrosis algorithms to replace transient elastography to exclude cirrhosis in people with hepatitis C virus infection: A multi-centre observational study.
    PLoS One. 2018;13:e0192763.
    PubMed     Text format     Abstract available


  21. ANADOL E, Lust K, Boesecke C, Schwarze-Zander C, et al
    Exposure to previous cART is associated with significant liver fibrosis and cirrhosis in human immunodeficiency virus-infected patients.
    PLoS One. 2018;13:e0191118.
    PubMed     Text format     Abstract available


  22. RATTANAVIPAPONG W, Anothaisintawee T, Teerawattananon Y
    Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis.
    PLoS One. 2018;13:e0193112.
    PubMed     Text format     Abstract available


  23. TARAMASSO L, Di Biagio A, Bovis F, Nicolini LA, et al
    Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir +/- ribavirin in HIV/HCV co-infected patients.
    PLoS One. 2018;13:e0192627.
    PubMed     Text format     Abstract available


  24. AMBACHEW H, Zheng M, Pappoe F, Shen J, et al
    Genotyping and sero-virological characterization of hepatitis B virus (HBV) in blood donors, Southern Ethiopia.
    PLoS One. 2018;13:e0193177.
    PubMed     Text format     Abstract available


  25. CHENG PN, Chiu YC, Chiu HC, Chien SC, et al
    The characteristics of residents with unawareness of hepatitis C virus infection in community.
    PLoS One. 2018;13:e0193251.
    PubMed     Text format     Abstract available


  26. MAPOURE NY, Budzi MN, Eloumou SAFB, Malongue A, et al
    Neurological manifestations in chronic hepatitis C patients receiving care in a reference hospital in sub-Saharan Africa: A cross-sectional study.
    PLoS One. 2018;13:e0192406.
    PubMed     Text format     Abstract available


  27. BALSITIS S, Gali V, Mason PJ, Chaniewski S, et al
    Safety and efficacy of anti-PD-L1 therapy in the woodchuck model of HBV infection.
    PLoS One. 2018;13:e0190058.
    PubMed     Text format     Abstract available


  28. MAUNOURY F, Clement A, Nwankwo C, Levy-Bachelot L, et al
    Cost-effectiveness analysis of elbasvir-grazoprevir regimen for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France.
    PLoS One. 2018;13:e0194329.
    PubMed     Text format     Abstract available


  29. AN J, Kim JW, Shim JH, Han S, et al
    Chronic hepatitis B infection and non-hepatocellular cancers: A hospital registry-based, case-control study.
    PLoS One. 2018;13:e0193232.
    PubMed     Text format     Abstract available


  30. DI POTO C, He S, Varghese RS, Zhao Y, et al
    Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection.
    PLoS One. 2018;13:e0192748.
    PubMed     Text format     Abstract available


  31. MOTOYAMA H, Tamori A, Kubo S, Uchida-Kobayashi S, et al
    Stagnation of histopathological improvement is a predictor of hepatocellular carcinoma development after hepatitis C virus eradication.
    PLoS One. 2018;13:e0194163.
    PubMed     Text format     Abstract available


  32. ZEKRI AN, El-Sisi ER, Youssef ASE, Kamel MM, et al
    MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection.
    PLoS One. 2018;13:e0193709.
    PubMed     Text format     Abstract available


  33. CARABALLO CORTES K, Rosinska M, Janiak M, Stepien M, et al
    Next-generation sequencing analysis of a cluster of hepatitis C virus infections in a haematology and oncology center.
    PLoS One. 2018;13:e0194816.
    PubMed     Text format     Abstract available


  34. SAUVAGE V, Boizeau L, Candotti D, Vandenbogaert M, et al
    Early MinION nanopore single-molecule sequencing technology enables the characterization of hepatitis B virus genetic complexity in clinical samples.
    PLoS One. 2018;13:e0194366.
    PubMed     Text format     Abstract available


  35. NEMOZ B, Roger L, Leroy V, Poveda JD, et al
    Evaluation of the cobas(R) GT hepatitis C virus genotyping assay in G1-6 viruses including low viral loads and LiPA failures.
    PLoS One. 2018;13:e0194396.
    PubMed     Text format     Abstract available


  36. NGUYEN HH, Shaheen AA, Baeza N, Lytvyak E, et al
    Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
    PLoS One. 2018;13:e0193960.
    PubMed     Text format     Abstract available


  37. LI CW, Yang CJ, Sun HY, Tsai MS, et al
    Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan.
    PLoS One. 2018;13:e0194149.
    PubMed     Text format     Abstract available


  38. BRAND RF, Rostal MK, Kemp A, Anyamba A, et al
    A phytosociological analysis and description of wetland vegetation and ecological factors associated with locations of high mortality for the 2010-11 Rift Valley fever outbreak in South Africa.
    PLoS One. 2018;13:e0191585.
    PubMed     Text format     Abstract available


  39. DES JARLAIS DC, Cooper HLF, Arasteh K, Feelemyer J, et al
    Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US.
    PLoS One. 2018;13:e0194799.
    PubMed     Text format     Abstract available



  40. Retraction: rs10499194 polymorphism in the tumor necrosis factor-alpha inducible protein 3 (TNFAIP3) gene is associated with type-1 autoimmune hepatitis risk in Chinese Han population.
    PLoS One. 2018;13:e0195181.
    PubMed     Text format    


  41. TI L, Socias ME, Wood E, Milloy MJ, et al
    The impact of methadone maintenance therapy on access to regular physician care regarding hepatitis C among people who inject drugs.
    PLoS One. 2018;13:e0194162.
    PubMed     Text format     Abstract available


  42. KHAN T, Zaman G, Saleh Alshomrani A
    Spreading dynamic of acute and carrier hepatitis B with nonlinear incidence.
    PLoS One. 2018;13:e0191914.
    PubMed     Text format     Abstract available


  43. YAMAZAKI T, Joshita S, Umemura T, Usami Y, et al
    Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C.
    PLoS One. 2018;13:e0195632.
    PubMed     Text format     Abstract available


  44. GOLIZEH M, Melendez-Pena CE, Ward BJ, Saeed S, et al
    Proteomic fingerprinting in HIV/HCV co-infection reveals serum biomarkers for the diagnosis of fibrosis staging.
    PLoS One. 2018;13:e0195148.
    PubMed     Text format     Abstract available


  45. BELYHUN Y, Liebert UG, Maier M
    Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia.
    PLoS One. 2018;13:e0191970.
    PubMed     Text format     Abstract available


  46. DE LA FUENTE C, Pinkham C, Dabbagh D, Beitzel B, et al
    Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection.
    PLoS One. 2018;13:e0191983.
    PubMed     Text format     Abstract available


  47. EKO MBA JM, Bisseye C, Ntsame Ndong JM, Mombo LE, et al
    Prevalent hepatitis B surface antigen among first-time blood donors in Gabon.
    PLoS One. 2018;13:e0194285.
    PubMed     Text format     Abstract available


  48. HAN B, Yuan Q, Shi Y, Wei L, et al
    The experience of discrimination of individuals living with chronic hepatitis B in four provinces of China.
    PLoS One. 2018;13:e0195455.
    PubMed     Text format     Abstract available


  49. FACENTE SN, Grebe E, Burk K, Morris MD, et al
    Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination.
    PLoS One. 2018;13:e0195575.
    PubMed     Text format     Abstract available


  50. FRIEDMAN A, Siewe N
    Chronic hepatitis B virus and liver fibrosis: A mathematical model.
    PLoS One. 2018;13:e0195037.
    PubMed     Text format     Abstract available


  51. HUGHES E, Hopkins LJ, Parker R
    Correction: Survival from alcoholic hepatitis has not improved over time.
    PLoS One. 2018;13:e0195857.
    PubMed     Text format     Abstract available


  52. LU Y, Jin X, Duan CA, Chang F, et al
    Cost-effectiveness of daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b treatment-naive patients in China.
    PLoS One. 2018;13:e0195117.
    PubMed     Text format     Abstract available


  53. HAMADA K, Saitoh S, Nishino N, Fukushima D, et al
    Shear wave elastography predicts hepatocellular carcinoma risk in hepatitis C patients after sustained virological response.
    PLoS One. 2018;13:e0195173.
    PubMed     Text format     Abstract available


  54. MASHIBA T, Joko K, Kurosaki M, Ochi H, et al
    Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group.
    PLoS One. 2018;13:e0194704.
    PubMed     Text format     Abstract available


    January 2017
  55. LIU S, Zhao K, Su X, Lu L, et al
    MITA/STING and Its Alternative Splicing Isoform MRP Restrict Hepatitis B Virus Replication.
    PLoS One. 2017;12:e0169701.
    PubMed     Text format     Abstract available


  56. ASSELAH T, Moreno C, Sarrazin C, Gschwantler M, et al
    Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naive Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response.
    PLoS One. 2017;12:e0168713.
    PubMed     Text format     Abstract available


  57. ZHU Z, Tran H, Mathahs MM, Moninger TO, et al
    HCV Induces Telomerase Reverse Transcriptase, Increases Its Catalytic Activity, and Promotes Caspase Degradation in Infected Human Hepatocytes.
    PLoS One. 2017;12:e0166853.
    PubMed     Text format     Abstract available


  58. WANG SC, Lai KR, Li CY, Chiang CS, et al
    The Paradoxical Effects of Different Hepatitis C Viral Loads on Host DNA Damage and Repair Abilities.
    PLoS One. 2017;12:e0164281.
    PubMed     Text format     Abstract available


  59. STAHMEYER JT, Rossol S, Liersch S, Guerra I, et al
    Cost-Effectiveness of Treating Hepatitis C with Sofosbuvir/Ledipasvir in Germany.
    PLoS One. 2017;12:e0169401.
    PubMed     Text format     Abstract available


  60. HOSSAIN MG, Ueda K
    Investigation of a Novel Hepatitis B Virus Surface Antigen (HBsAg) Escape Mutant Affecting Immunogenicity.
    PLoS One. 2017;12:e0167871.
    PubMed     Text format     Abstract available


  61. PUGA MA, Bandeira LM, Pompilio MA, Croda J, et al
    Prevalence and Incidence of HCV Infection among Prisoners in Central Brazil.
    PLoS One. 2017;12:e0169195.
    PubMed     Text format     Abstract available


  62. KIM DY, Han KH, Jun B, Kim TH, et al
    Estimating the Cost-Effectiveness of One-Time Screening and Treatment for Hepatitis C in Korea.
    PLoS One. 2017;12:e0167770.
    PubMed     Text format     Abstract available


  63. WANG J, Su C, Liu R, Liu B, et al
    A Pre-Clinical Safety Evaluation of SBP (HBsAg-Binding Protein) Adjuvant for Hepatitis B Vaccine.
    PLoS One. 2017;12:e0170313.
    PubMed     Text format     Abstract available


  64. HU J, Gu X, Tao X, Qian Y, et al
    Prevalence and Trends of HIV, Syphilis, and HCV in Migrant and Resident Men Who Have Sex with Men in Shandong, China: Results from a Serial Cross-Sectional Study.
    PLoS One. 2017;12:e0170443.
    PubMed     Text format     Abstract available


  65. KIM KA, Lee A, Ki M, Jeong SH, et al
    Nationwide Seropositivity of Hepatitis A in Republic of Korea from 2005 to 2014, before and after the Outbreak Peak in 2009.
    PLoS One. 2017;12:e0170432.
    PubMed     Text format     Abstract available


  66. NAM JY, Lee JH, Kim HY, Kim JE, et al
    Oral Medications Enhance Adherence to Surveillance for Hepatocellular Carcinoma and Survival in Chronic Hepatitis B Patients.
    PLoS One. 2017;12:e0166188.
    PubMed     Text format     Abstract available


  67. WU Q, An J, She R, Shi R, et al
    Detection of Genotype 4 Swine Hepatitis E Virus in Systemic Tissues in Cross-Species Infected Rabbits.
    PLoS One. 2017;12:e0171277.
    PubMed     Text format     Abstract available


  68. DEGRE D, Serste T, Lasser L, Delwaide J, et al
    Sofosbuvir in Combination with Simeprevir +/- Ribavirin in Genotype 4 Hepatitis C Patients with Advanced Fibrosis or Cirrhosis: A Real-World Experience from Belgium.
    PLoS One. 2017;12:e0170933.
    PubMed     Text format     Abstract available


  69. APPELMAN MD, Chakraborty A, Protzer U, McKeating JA, et al
    N-Glycosylation of the Na+-Taurocholate Cotransporting Polypeptide (NTCP) Determines Its Trafficking and Stability and Is Required for Hepatitis B Virus Infection.
    PLoS One. 2017;12:e0170419.
    PubMed     Text format     Abstract available


  70. INOUE T, Hmwe SS, Shimada N, Kato K, et al
    Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy.
    PLoS One. 2017;12:e0170667.
    PubMed     Text format     Abstract available


  71. AHN HJ, Song MJ, Jang JW, Bae SH, et al
    Treatment Efficacy and Safety of Tenofovir-Based Therapy in Chronic Hepatitis B: A Real Life Cohort Study in Korea.
    PLoS One. 2017;12:e0170362.
    PubMed     Text format     Abstract available


  72. ZHAI N, Li H, Song H, Yang Y, et al
    Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling.
    PLoS One. 2017;12:e0170516.
    PubMed     Text format     Abstract available


  73. GAMBATO M, Caro-Perez N, Gonzalez P, Canete N, et al
    Correction: Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon.
    PLoS One. 2017;12:e0170913.
    PubMed     Text format     Abstract available


  74. TSUTSUMI T, Okushin K, Enooku K, Fujinaga H, et al
    Nonstructural 5A Protein of Hepatitis C Virus Interferes with Toll-Like Receptor Signaling and Suppresses the Interferon Response in Mouse Liver.
    PLoS One. 2017;12:e0170461.
    PubMed     Text format     Abstract available


  75. NIEN HC, Hsu SJ, Su TH, Yang PJ, et al
    High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments.
    PLoS One. 2017;12:e0170028.
    PubMed     Text format     Abstract available


  76. XING T, Xu H, Cao L, Ye M, et al
    HBeAg Seroconversion in HBeAg-Positive Chronic Hepatitis B Patients Receiving Long-Term Nucleos(t)ide Analog Treatment: A Systematic Review and Network Meta-Analysis.
    PLoS One. 2017;12:e0169444.
    PubMed     Text format     Abstract available


  77. CASCIANO JC, Duchemin NJ, Lamontagne RJ, Steel LF, et al
    Hepatitis B virus modulates store-operated calcium entry to enhance viral replication in primary hepatocytes.
    PLoS One. 2017;12:e0168328.
    PubMed     Text format     Abstract available


  78. WU B, Xiao F, Li P, Du Y, et al
    Ultrasensitive detection of serum hepatitis B virus by coupling ultrafiltration DNA extraction with real-time PCR.
    PLoS One. 2017;12:e0170290.
    PubMed     Text format     Abstract available


  79. ZHANG C, Hua R, Cui Y, Wang S, et al
    Comprehensive mapping of antigen specific T cell responses in hepatitis C virus infected patients with or without spontaneous viral clearance.
    PLoS One. 2017;12:e0171217.
    PubMed     Text format     Abstract available


  80. WELSCH C, Efinger M, von Wagner M, Herrmann E, et al
    Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response.
    PLoS One. 2017;12:e0171755.
    PubMed     Text format     Abstract available


  81. RUIZ-EXTREMERA A, Pavon-Castillero EJ, Florido M, Munoz de Rueda P, et al
    Influence of HLA class I, HLA class II and KIRs on vertical transmission and chronicity of hepatitis C virus in children.
    PLoS One. 2017;12:e0172527.
    PubMed     Text format     Abstract available


  82. MIYAKI E, Hiraga N, Imamura M, Uchida T, et al
    Interferon alpha treatment stimulates interferon gamma expression in type I NKT cells and enhances their antiviral effect against hepatitis C virus.
    PLoS One. 2017;12:e0172412.
    PubMed     Text format     Abstract available


  83. KONDILI LA, Gaeta GB, Ieluzzi D, Zignego AL, et al
    Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study.
    PLoS One. 2017;12:e0172159.
    PubMed     Text format     Abstract available


  84. LIN SY, Lin CL, Ju SW, Wang IK, et al
    Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study.
    PLoS One. 2017;12:e0173125.
    PubMed     Text format     Abstract available


  85. THANAPIROM K, Suksawatamnuay S, Sukeepaisarnjareon W, Tanwandee T, et al
    Genetic variation in the vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study.
    PLoS One. 2017;12:e0173263.
    PubMed     Text format     Abstract available


  86. COUTO I, Victoria M, Veloso VG, Rodrigues L, et al
    Prevalence and predictors for compensated Advanced Chronic Liver Disease (c-ACLD) in patients with chronic Hepatitis Delta Virus (HDV) infection.
    PLoS One. 2017;12:e0174453.
    PubMed     Text format     Abstract available


  87. GARDINALI NR, Guimaraes JR, Melgaco JG, Kevorkian YB, et al
    Cynomolgus monkeys are successfully and persistently infected with hepatitis E virus genotype 3 (HEV-3) after long-term immunosuppressive therapy.
    PLoS One. 2017;12:e0174070.
    PubMed     Text format     Abstract available


  88. YOSHIOKA T, Tatsumi T, Miyagi T, Mukai K, et al
    Frequency and role of NKp46 and NKG2A in hepatitis B virus infection.
    PLoS One. 2017;12:e0174103.
    PubMed     Text format     Abstract available


  89. RALLON N, Garcia M, Garcia-Samaniego J, Rodriguez N, et al
    HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells.
    PLoS One. 2017;12:e0173943.
    PubMed     Text format     Abstract available


  90. GUPTA N, Kabahizi J, Mukabatsinda C, Walker TD, et al
    "Waiting for DAAs": A retrospective chart review of patients with untreated hepatitis C in Rwanda.
    PLoS One. 2017;12:e0174148.
    PubMed     Text format     Abstract available


  91. GUINOISEAU T, Moreau A, Hohnadel G, Ngo-Giang-Huong N, et al
    Deep sequencing is an appropriate tool for the selection of unique Hepatitis C virus (HCV) variants after single genomic amplification.
    PLoS One. 2017;12:e0174852.
    PubMed     Text format     Abstract available


  92. HUANG YJ, Chang CS, Peng YC, Yeh HZ, et al
    On-treatment HBV DNA dynamics predict virological breakthrough in entecavir-treated HBeAg-positive chronic hepatitis B.
    PLoS One. 2017;12:e0174046.
    PubMed     Text format     Abstract available


  93. LOWE PP, Gyongyosi B, Satishchandran A, Iracheta-Vellve A, et al
    Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice.
    PLoS One. 2017;12:e0174544.
    PubMed     Text format     Abstract available


  94. CHEN HC, Chung CH, Wang CH, Lin JC, et al
    Increased risk of sudden sensorineural hearing loss in patients with hepatitis virus infection.
    PLoS One. 2017;12:e0175266.
    PubMed     Text format     Abstract available


  95. YE Q, Yin W, Zhang L, Xiao H, et al
    The value of grip test, lysophosphatidlycholines, glycerophosphocholine, ornithine, glucuronic acid decrement in assessment of nutritional and metabolic characteristics in hepatitis B cirrhosis.
    PLoS One. 2017;12:e0175165.
    PubMed     Text format     Abstract available


  96. KACZMAREK DJ, Kokordelis P, Kramer B, Glassner A, et al
    Alterations of the NK cell pool in HIV/HCV co-infection.
    PLoS One. 2017;12:e0174465.
    PubMed     Text format     Abstract available


  97. CHEN H, Chen L
    Estimating cost-effectiveness associated with all-oral regimen for chronic hepatitis C in China.
    PLoS One. 2017;12:e0175189.
    PubMed     Text format     Abstract available


  98. KOMOLMIT P, Charoensuk K, Thanapirom K, Suksawatamnuay S, et al
    Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial.
    PLoS One. 2017;12:e0174608.
    PubMed     Text format     Abstract available


  99. FERNANDEZ-CABALLERO JA, Alvarez M, Chueca N, Perez AB, et al
    The cobas(R) HCV GT is a new tool that accurately identifies Hepatitis C virus genotypes for clinical practice.
    PLoS One. 2017;12:e0175564.
    PubMed     Text format     Abstract available


  100. YANG CM, Yoon JC, Park JH, Lee JM, et al
    Hepatitis C virus impairs natural killer cell activity via viral serine protease NS3.
    PLoS One. 2017;12:e0175793.
    PubMed     Text format     Abstract available


  101. CHLIBEK R, Smetana J, Sosovickova R, Gal P, et al
    Prevalence of hepatitis C virus in adult population in the Czech Republic - time for birth cohort screening.
    PLoS One. 2017;12:e0175525.
    PubMed     Text format     Abstract available


  102. NGUYEN HM, Sy BT, Trung NT, Hoan NX, et al
    Prevalence and genotype distribution of hepatitis delta virus among chronic hepatitis B carriers in Central Vietnam.
    PLoS One. 2017;12:e0175304.
    PubMed     Text format     Abstract available


  103. DU H, Yang J, Bai J, Ming K, et al
    A flavone-polysaccharide based prescription attenuates the mitochondrial dysfunction induced by duck hepatitis A virus type 1.
    PLoS One. 2017;12:e0175495.
    PubMed     Text format     Abstract available


  104. LE GUILLOU-GUILLEMETTE H, Pivert A, Bouthry E, Henquell C, et al
    Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma.
    PLoS One. 2017;12:e0174651.
    PubMed     Text format     Abstract available


  105. FAN Z, EnQiang C, Yao DL, LiBo Y, et al
    Neutrophil-lymphocyte ratio predicts short term mortality in patients with hepatitis B virus-related acute-on-chronic liver failure treated with an artificial liver support system.
    PLoS One. 2017;12:e0175332.
    PubMed     Text format     Abstract available


  106. NEFFATTI H, Lebraud P, Hottelet C, Gharbi J, et al
    Southern Tunisia: A still high endemicity area for hepatitis A.
    PLoS One. 2017;12:e0175887.
    PubMed     Text format     Abstract available


  107. XU E, Cao H, Lin L, Liu H, et al
    rs10499194 polymorphism in the tumor necrosis factor-alpha inducible protein 3 (TNFAIP3) gene is associated with type-1 autoimmune hepatitis risk in Chinese Han population.
    PLoS One. 2017;12:e0176471.
    PubMed     Text format     Abstract available


  108. CAPILENO YA, Van den Bergh R, Donchunk D, Hinderaker SG, et al
    Management of chronic Hepatitis C at a primary health clinic in the high-burden context of Karachi, Pakistan.
    PLoS One. 2017;12:e0175562.
    PubMed     Text format     Abstract available


  109. SLOT E, Zaaijer HL, Molier M, Van den Hurk K, et al
    Meat consumption is a major risk factor for hepatitis E virus infection.
    PLoS One. 2017;12:e0176414.
    PubMed     Text format     Abstract available


  110. PENE V, Lemasson M, Harper F, Pierron G, et al
    Role of cleavage at the core-E1 junction of hepatitis C virus polyprotein in viral morphogenesis.
    PLoS One. 2017;12:e0175810.
    PubMed     Text format     Abstract available


  111. JEONG H, Baek SY, Kim SW, Eun YH, et al
    Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey.
    PLoS One. 2017;12:e0176260.
    PubMed     Text format     Abstract available


  112. FRIAS M, Rivero-Juarez A, Tellez F, Perez-Perez M, et al
    Spontaneous clearance of chronic hepatitis C is rare in HIV-infected patients after effective use of combination antiretroviral therapy.
    PLoS One. 2017;12:e0177141.
    PubMed     Text format     Abstract available


  113. GENCAY M, Hubner K, Gohl P, Seffner A, et al
    Ultra-deep sequencing reveals high prevalence and broad structural diversity of hepatitis B surface antigen mutations in a global population.
    PLoS One. 2017;12:e0172101.
    PubMed     Text format     Abstract available


  114. MOQUEET N, Kanagaratham C, Gill MJ, Hull M, et al
    A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection.
    PLoS One. 2017;12:e0176282.
    PubMed     Text format     Abstract available


  115. DIRKSEN K, Spee B, Penning LC, van den Ingh TSGAM, et al
    Gene expression patterns in the progression of canine copper-associated chronic hepatitis.
    PLoS One. 2017;12:e0176826.
    PubMed     Text format     Abstract available


  116. SUN J, Robinson L, Lee NL, Welles S, et al
    No contribution of lifestyle and environmental exposures to gender discrepancy of liver disease severity in chronic hepatitis b infection: Observations from the Haimen City cohort.
    PLoS One. 2017;12:e0175482.
    PubMed     Text format     Abstract available


  117. BIRGER RB, Le T, Kouyos RD, Grenfell BT, et al
    The impact of HCV therapy in a high HIV-HCV prevalence population: A modeling study on people who inject drugs in Ho Chi Minh City, Vietnam.
    PLoS One. 2017;12:e0177195.
    PubMed     Text format     Abstract available


  118. PANDOLFI R, Ramos de Almeida D, Alves Pinto M, Kreutz LC, et al
    In house ELISA based on recombinant ORF2 protein underline high prevalence of IgG anti-hepatitis E virus amongst blood donors in south Brazil.
    PLoS One. 2017;12:e0176409.
    PubMed     Text format     Abstract available


  119. CHANG CC, Hsu HJ, Yen JH, Lo SY, et al
    A Sequence in the loop domain of hepatitis C virus E2 protein identified in silico as crucial for the selective binding to human CD81.
    PLoS One. 2017;12:e0177383.
    PubMed     Text format     Abstract available


  120. NAKAMURA M, Kanda T, Jiang X, Haga Y, et al
    Serum microRNA-122 and Wisteria floribunda agglutinin-positive Mac-2 binding protein are useful tools for liquid biopsy of the patients with hepatitis B virus and advanced liver fibrosis.
    PLoS One. 2017;12:e0177302.
    PubMed     Text format     Abstract available


  121. WASITTHANKASEM R, Vichaiwattana P, Siripon N, Posuwan N, et al
    Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence.
    PLoS One. 2017;12:e0177022.
    PubMed     Text format     Abstract available


  122. BAEZ PA, Lopez MC, Duque-Jaramillo A, Pelaez D, et al
    First evidence of the Hepatitis E virus in environmental waters in Colombia.
    PLoS One. 2017;12:e0177525.
    PubMed     Text format     Abstract available


  123. D'ARMINIO MONFORTE A, Cozzi-Lepri A, Ceccherini-Silberstein F, De Luca A, et al
    Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort.
    PLoS One. 2017;12:e0177402.
    PubMed     Text format     Abstract available


  124. AGGARWAL R, Chen Q, Goel A, Seguy N, et al
    Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India.
    PLoS One. 2017;12:e0176503.
    PubMed     Text format     Abstract available


  125. CENTO V, Nguyen THT, Di Carlo D, Biliotti E, et al
    Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens.
    PLoS One. 2017;12:e0177352.
    PubMed     Text format     Abstract available


  126. ECKHARDT B, Winkelstein ER, Shu MA, Carden MR, et al
    Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention.
    PLoS One. 2017;12:e0177341.
    PubMed     Text format     Abstract available


  127. JANG Y, Kim JH, Lee K
    Validation of the revised piper fatigue scale in Koreans with chronic hepatitis B.
    PLoS One. 2017;12:e0177690.
    PubMed     Text format     Abstract available


  128. HAN Z, Yin Y, Zhang Y, Ehrhardt S, et al
    Knowledge of and attitudes towards hepatitis B and its transmission from mother to child among pregnant women in Guangdong Province, China.
    PLoS One. 2017;12:e0178671.
    PubMed     Text format     Abstract available


  129. HUNDIE GB, Raj VS, GebreMichael D, Pas SD, et al
    Genetic diversity of hepatitis C virus in Ethiopia.
    PLoS One. 2017;12:e0179064.
    PubMed     Text format     Abstract available


  130. LOWE PP, Gyongyosi B, Satishchandran A, Iracheta-Vellve A, et al
    Correction: Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice.
    PLoS One. 2017;12:e0179070.
    PubMed     Text format     Abstract available


  131. ZHENG H, Zou AE, Saad MA, Wang XQ, et al
    Alcohol-dysregulated microRNAs in hepatitis B virus-related hepatocellular carcinoma.
    PLoS One. 2017;12:e0178547.
    PubMed     Text format     Abstract available


  132. NAIK AS, Owsianka A, Palmer BA, O'Halloran CJ, et al
    Reverse epitope mapping of the E2 glycoprotein in antibody associated hepatitis C virus.
    PLoS One. 2017;12:e0175349.
    PubMed     Text format     Abstract available


  133. EL HADAD S, Al-Hamdan H, Linjawi S
    Partial sequencing analysis of the NS5B region confirmed the predominance of hepatitis C virus genotype 1 infection in Jeddah, Saudi Arabia.
    PLoS One. 2017;12:e0178225.
    PubMed     Text format     Abstract available


  134. JANG TY, Lin PC, Huang CI, Liao YM, et al
    Seroprevalence and clinical characteristics of viral hepatitis in transfusion-dependent thalassemia and hemophilia patients.
    PLoS One. 2017;12:e0178883.
    PubMed     Text format     Abstract available


  135. TAUBERT R, Hardtke-Wolenski M, Noyan F, Lalanne C, et al
    Hyperferritinemia and hypergammaglobulinemia predict the treatment response to standard therapy in autoimmune hepatitis.
    PLoS One. 2017;12:e0179074.
    PubMed     Text format     Abstract available


  136. CHIU NC, Su CW, Liu CA, Huang YH, et al
    Interval to vascularization development in cirrhotic precursor nodules in patients with hepatitis B and C virus co-infections.
    PLoS One. 2017;12:e0178841.
    PubMed     Text format     Abstract available


  137. SAHA D, Pal A, Sarkar N, Das D, et al
    Occult hepatitis B virus infection in HIV positive patients at a tertiary healthcare unit in eastern India.
    PLoS One. 2017;12:e0179035.
    PubMed     Text format     Abstract available


  138. HARRIS BJ, Holzmayer V, Qureshi H, Khan MA, et al
    Hepatitis B genotypes and surface antigen mutants present in Pakistani blood donors.
    PLoS One. 2017;12:e0178988.
    PubMed     Text format     Abstract available


  139. ALVARO-MECA A, Berenguer J, Diaz A, Micheloud D, et al
    Stroke in HIV-infected individuals with and without HCV coinfection in Spain in the combination antiretroviral therapy era.
    PLoS One. 2017;12:e0179493.
    PubMed     Text format     Abstract available


  140. CHU PS, Nakamoto N, Taniki N, Ojiro K, et al
    On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C.
    PLoS One. 2017;12:e0179096.
    PubMed     Text format     Abstract available


  141. NDOW G, Gore ML, Shimakawa Y, Suso P, et al
    Hepatitis B testing and treatment in HIV patients in The Gambia-Compliance with international guidelines and clinical outcomes.
    PLoS One. 2017;12:e0179025.
    PubMed     Text format     Abstract available


  142. LEE JW, Kim W, Kwon EK, Kim Y, et al
    Immunological dynamics associated with rapid virological response during the early phase of type I interferon therapy in patients with chronic hepatitis C.
    PLoS One. 2017;12:e0179094.
    PubMed     Text format     Abstract available


  143. CHENG ST, Tang H, Ren JH, Chen X, et al
    Interleukin-34 inhibits hepatitis B virus replication in vitro and in vivo.
    PLoS One. 2017;12:e0179605.
    PubMed     Text format     Abstract available


  144. OU X, Mao S, Cao J, Cheng A, et al
    Comparative analysis of virus-host interactions caused by a virulent and an attenuated duck hepatitis A virus genotype 1.
    PLoS One. 2017;12:e0178993.
    PubMed     Text format     Abstract available


  145. WU YT, Li X, Liu ZL, Xu Z, et al
    Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0179680.
    PubMed     Text format     Abstract available


  146. CAPILENO YA, Van den Bergh R, Donchuk D, Hinderaker SG, et al
    Correction: Management of chronic Hepatitis C at a primary health clinic in the high-burden context of Karachi, Pakistan.
    PLoS One. 2017;12:e0180286.
    PubMed     Text format     Abstract available


  147. MASCIA C, Vita S, Zuccala P, Marocco R, et al
    Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon.
    PLoS One. 2017;12:e0179400.
    PubMed     Text format     Abstract available


  148. ELSHERIF O, Bannan C, Keating S, McKiernan S, et al
    Outcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic response.
    PLoS One. 2017;12:e0178398.
    PubMed     Text format     Abstract available


  149. GUILLOT C, Martel N, Berby F, Bordes I, et al
    Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes.
    PLoS One. 2017;12:e0179697.
    PubMed     Text format     Abstract available


  150. LIN HC, Xirasagar S, Lee HC, Huang CC, et al
    Association of Alzhemier's disease with hepatitis C among patients with bipolar disorder.
    PLoS One. 2017;12:e0179312.
    PubMed     Text format     Abstract available


  151. LIU Z, Li S, Liu Y, Guo W, et al
    PD1 is highly expressed in diffuse large B-cell lymphoma with hepatitis B virus infection.
    PLoS One. 2017;12:e0180390.
    PubMed     Text format     Abstract available


  152. ISHIZAKI A, Tran VT, Nguyen CH, Tanimoto T, et al
    Discrepancies in prevalence trends for HIV, hepatitis B virus, and hepatitis C virus in Haiphong, Vietnam from 2007 to 2012.
    PLoS One. 2017;12:e0179616.
    PubMed     Text format     Abstract available


  153. LIU T, Wang F, Zhang S, Wang F, et al
    Whole-gene analysis of two groups of hepatitis B virus C/D inter-genotype recombinant strains isolated in Tibet, China.
    PLoS One. 2017;12:e0179846.
    PubMed     Text format     Abstract available


  154. BELAUNZARAN-ZAMUDIO PF, Mosqueda-Gomez JL, Macias-Hernandez A, Sierra-Madero JG, et al
    Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
    PLoS One. 2017;12:e0179931.
    PubMed     Text format     Abstract available


  155. ABEBE M, Ali I, Ayele S, Overbo J, et al
    Seroprevalence and risk factors of Hepatitis E Virus infection among pregnant women in Addis Ababa, Ethiopia.
    PLoS One. 2017;12:e0180078.
    PubMed     Text format     Abstract available


  156. SHIU TY, Huang SM, Shih YL, Chu HC, et al
    Correction: Hepatitis C Virus Core Protein Down-Regulates p21Waf1/Cip1 and Inhibits Curcumin-Induced Apoptosis through MicroRNA-345 Targeting in Human Hepatoma Cells.
    PLoS One. 2017;12:e0181299.
    PubMed     Text format     Abstract available


  157. SNOW KJ, Richards AH, Kinner SA
    Use of multiple data sources to estimate hepatitis C seroprevalence among prisoners: A retrospective cohort study.
    PLoS One. 2017;12:e0180646.
    PubMed     Text format     Abstract available


  158. RENDON JC, Cortes-Mancera F, Restrepo-Gutierrez JC, Hoyos S, et al
    Molecular characterization of occult hepatitis B virus infection in patients with end-stage liver disease in Colombia.
    PLoS One. 2017;12:e0180447.
    PubMed     Text format     Abstract available


  159. LEVENTER-ROBERTS M, Hammerman A, Brufman I, Hoshen M, et al
    Effectiveness of dasabuvir/ombitasvir/paritaprevir/ritonavir for hepatitis C virus in clinical practice: A population-based observational study.
    PLoS One. 2017;12:e0176858.
    PubMed     Text format     Abstract available


  160. JANG YR, Shin Y, Jin CE, Koo B, et al
    Molecular detection of Coxiella burnetii from the formalin-fixed tissues of Q fever patients with acute hepatitis.
    PLoS One. 2017;12:e0180237.
    PubMed     Text format     Abstract available


  161. LOPEZ-RODRIGUEZ R, Hernandez-Bartolome A, Borque MJ, Rodriguez-Munoz Y, et al
    Interferon-related genetic markers of necroinflammatory activity in chronic hepatitis C.
    PLoS One. 2017;12:e0180927.
    PubMed     Text format     Abstract available


  162. DALGARD O, Weiland O, Noraberg G, Karlsen L, et al
    Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study.
    PLoS One. 2017;12:e0179764.
    PubMed     Text format     Abstract available


  163. DIESTELHORST J, Junge N, Schlue J, Falk CS, et al
    Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy.
    PLoS One. 2017;12:e0181107.
    PubMed     Text format     Abstract available


  164. ANDRE-GARNIER E, Besse B, Rodallec A, Ribeyrol O, et al
    An NS5A single optimized method to determine genotype, subtype and resistance profiles of Hepatitis C strains.
    PLoS One. 2017;12:e0179562.
    PubMed     Text format     Abstract available


  165. NEUKAM K, Martinez AP, Culasso ACA, Ridruejo E, et al
    NS3 genomic sequencing and phylogenetic analysis as alternative to a commercially available assay to reliably determine hepatitis C virus subtypes 1a and 1b.
    PLoS One. 2017;12:e0182193.
    PubMed     Text format     Abstract available


  166. MATSUO J, Do SH, Yamamoto C, Nagashima S, et al
    Clustering infection of hepatitis B virus genotype B4 among residents in Vietnam, and its genomic characters both intra- and extra-family.
    PLoS One. 2017;12:e0177248.
    PubMed     Text format     Abstract available


  167. RUSSELLI G, Pizzillo P, Iannolo G, Barbera F, et al
    HCV replication in gastrointestinal mucosa: Potential extra-hepatic viral reservoir and possible role in HCV infection recurrence after liver transplantation.
    PLoS One. 2017;12:e0181683.
    PubMed     Text format     Abstract available


  168. SABET S, George MA, El-Shorbagy HM, Bassiony H, et al
    Gelatin nanoparticles enhance delivery of hepatitis C virus recombinant NS2 gene.
    PLoS One. 2017;12:e0181723.
    PubMed     Text format     Abstract available


  169. MERDAN M, Bekiryazici Z, Kesemen T, Khaniyev T, et al
    Deterministic stability and random behavior of a Hepatitis C model.
    PLoS One. 2017;12:e0181571.
    PubMed     Text format     Abstract available


  170. STELZL E, Haas B, Bauer B, Zhang S, et al
    First identification of a recombinant form of hepatitis C virus in Austrian patients by full-genome next generation sequencing.
    PLoS One. 2017;12:e0181273.
    PubMed     Text format     Abstract available


  171. CHOTUN N, Preiser W, van Rensburg CJ, Fernandez P, et al
    Point-of-care screening for hepatitis B virus infection in pregnant women at an antenatal clinic: A South African experience.
    PLoS One. 2017;12:e0181267.
    PubMed     Text format     Abstract available


  172. TAN WG, Zubkova I, Kachko A, Wells F, et al
    Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.
    PLoS One. 2017;12:e0181578.
    PubMed     Text format     Abstract available


  173. HUGHES MG JR, Tucker WW, Reddy S, Brier ME, et al
    Rate of hepatitis C viral clearance by human livers in human patients: Liver transplantation modeling primary infection and implications for studying entry inhibition.
    PLoS One. 2017;12:e0180719.
    PubMed     Text format     Abstract available


  174. KIM BH, Choi HY, Ki M, Kim KA, et al
    Population-based prevalence, incidence, and disease burden of autoimmune hepatitis in South Korea.
    PLoS One. 2017;12:e0182391.
    PubMed     Text format     Abstract available


  175. GOUVEIA LR, Santos JC, Silva RD, Batista AD, et al
    Diagnosis of coinfection by schistosomiasis and viral hepatitis B or C using 1H NMR-based metabonomics.
    PLoS One. 2017;12:e0182196.
    PubMed     Text format     Abstract available


  176. SAGNELLI C, Uberti-Foppa C, Hasson H, Bellini G, et al
    Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients.
    PLoS One. 2017;12:e0181890.
    PubMed     Text format     Abstract available


  177. NAGAOKI Y, Imamura M, Aikata H, Daijo K, et al
    The risks of hepatocellular carcinoma development after HCV eradication are similar between patients treated with peg-interferon plus ribavirin and direct-acting antiviral therapy.
    PLoS One. 2017;12:e0182710.
    PubMed     Text format     Abstract available


  178. KIM YA, Trinh S, Thura S, Kyi KP, et al
    Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar.
    PLoS One. 2017;12:e0181603.
    PubMed     Text format     Abstract available


  179. HUANG CM, Chang KC, Hung CH, Chiu KW, et al
    Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C.
    PLoS One. 2017;12:e0182204.
    PubMed     Text format     Abstract available


  180. WISSKIRCHEN K, Metzger K, Schreiber S, Asen T, et al
    Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use.
    PLoS One. 2017;12:e0182936.
    PubMed     Text format     Abstract available


  181. GOSSELIN A, Lelievre E, Ravalihasy A, Lydie N, et al
    "Times Are Changing": The Impact of HIV Diagnosis on Sub-Saharan Migrants' Lives in France.
    PLoS One. 2017;12:e0170226.
    PubMed     Text format     Abstract available


  182. WU CK, Liang CM, Hsu CN, Hung TH, et al
    The Role of Adjuvant Acid Suppression on the Outcomes of Bleeding Esophageal Varices after Endoscopic Variceal Ligation.
    PLoS One. 2017;12:e0169884.
    PubMed     Text format     Abstract available


  183. NIU C, Livingston CM, Li L, Beran RK, et al
    The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection.
    PLoS One. 2017;12:e0169648.
    PubMed     Text format     Abstract available


  184. LIU X, He L, Han J, Wang L, et al
    Association of neutrophil-lymphocyte ratio and T lymphocytes with the pathogenesis and progression of HBV-associated primary liver cancer.
    PLoS One. 2017;12:e0170605.
    PubMed     Text format     Abstract available


  185. CHO YE, Im EJ, Moon PG, Mezey E, et al
    Increased liver-specific proteins in circulating extracellular vesicles as potential biomarkers for drug- and alcohol-induced liver injury.
    PLoS One. 2017;12:e0172463.
    PubMed     Text format     Abstract available


  186. DE WEGGHELEIRE A, An S, De Baetselier I, Soeung P, et al
    A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening.
    PLoS One. 2017;12:e0183530.
    PubMed     Text format     Abstract available


  187. BUTT ZA, Shrestha N, Wong S, Kuo M, et al
    A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British Columbia.
    PLoS One. 2017;12:e0183609.
    PubMed     Text format     Abstract available


  188. GUO G, Zhang L, Ye S, Hu Y, et al
    Polymorphisms and features of cytomegalovirus UL144 and UL146 in congenitally infected neonates with hepatic involvement.
    PLoS One. 2017;12:e0171959.
    PubMed     Text format     Abstract available


  189. CARRIERI MP, Marcellin F, Fressard L, Preau M, et al
    Suicide risk in a representative sample of people receiving HIV care: Time to target most-at-risk populations (ANRS VESPA2 French national survey).
    PLoS One. 2017;12:e0171645.
    PubMed     Text format     Abstract available


  190. MANICKAM C, Wachtman L, Martinot AJ, Giavedoni LD, et al
    Metabolic Dysregulation in Hepacivirus Infection of Common Marmosets (Callithrix jacchus).
    PLoS One. 2017;12:e0170240.
    PubMed     Text format     Abstract available


  191. MORSICA G, Bagaglio S, Spagnuolo V, Castagna A, et al
    Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study.
    PLoS One. 2017;12:e0184128.
    PubMed     Text format     Abstract available


  192. SHIER MK, Iles JC, El-Wetidy MS, Ali HH, et al
    Molecular characterization and epidemic history of hepatitis C virus using core sequences of isolates from Central Province, Saudi Arabia.
    PLoS One. 2017;12:e0184163.
    PubMed     Text format     Abstract available


  193. HERMETET C, Dubois F, Gaudy-Graffin C, Bacq Y, et al
    Continuum of hepatitis C care in France: A 20-year cohort study.
    PLoS One. 2017;12:e0183232.
    PubMed     Text format     Abstract available


  194. KJAERGAARD M, Thiele M, Jansen C, Staehr Madsen B, et al
    High risk of misinterpreting liver and spleen stiffness using 2D shear-wave and transient elastography after a moderate or high calorie meal.
    PLoS One. 2017;12:e0173992.
    PubMed     Text format     Abstract available


  195. GARBA RM, Gadanya MA
    The role of intervention mapping in designing disease prevention interventions: A systematic review of the literature.
    PLoS One. 2017;12:e0174438.
    PubMed     Text format     Abstract available


  196. ZHENG Z, Sze CW, Keng CT, Al-Haddawi M, et al
    Hepatitis C virus mediated chronic inflammation and tumorigenesis in the humanised immune system and liver mouse model.
    PLoS One. 2017;12:e0184127.
    PubMed     Text format     Abstract available


  197. DAVIES J, Li SQ, Tong SY, Baird RW, et al
    Establishing contemporary trends in hepatitis B sero-epidemiology in an Indigenous population.
    PLoS One. 2017;12:e0184082.
    PubMed     Text format     Abstract available


  198. GOMEZ-MORENO AZ, Pineda-Tenor D, Jimenez-Sousa MA, Sanchez-Ruano JJ, et al
    Liver stiffness measurement predicts liver-related events in patients with chronic hepatitis C: A retrospective study.
    PLoS One. 2017;12:e0184404.
    PubMed     Text format     Abstract available


  199. VUTIEN P, Jin M, Le MH, Nguyen P, et al
    Regional differences in treatment rates for patients with chronic hepatitis C infection: Systematic review and meta-analysis.
    PLoS One. 2017;12:e0183851.
    PubMed     Text format     Abstract available


  200. WANG L, Cao M, Wei QL, Zhao ZH, et al
    A new model mimicking persistent HBV e antigen-negative infection using covalently closed circular DNA in immunocompetent mice.
    PLoS One. 2017;12:e0175992.
    PubMed     Text format     Abstract available


  201. GONZALEZ R, De la Rosa AJ, Rufini A, Rodriguez-Hernandez MA, et al
    Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantation.
    PLoS One. 2017;12:e0174326.
    PubMed     Text format     Abstract available


  202. KEATING SM, Dodge JL, Norris PJ, Heitman J, et al
    The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study.
    PLoS One. 2017;12:e0181004.
    PubMed     Text format     Abstract available


  203. BUTI M, Manzano ML, Morillas RM, Garcia-Retortillo M, et al
    Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.
    PLoS One. 2017;12:e0184550.
    PubMed     Text format     Abstract available


  204. TUDESQ JJ, Dunyach-Remy C, Combescure C, Doncesco R, et al
    Microbial translocation is correlated with HIV evolution in HIV-HCV co-infected patients.
    PLoS One. 2017;12:e0183372.
    PubMed     Text format     Abstract available


  205. ROSINSKA M, Parda N, Kolakowska A, Godzik P, et al
    Factors associated with hepatitis C prevalence differ by the stage of liver fibrosis: A cross-sectional study in the general population in Poland, 2012-2016.
    PLoS One. 2017;12:e0185055.
    PubMed     Text format     Abstract available


  206. UITTE DE WILLIGE S, Keane FM, Bowen DG, Malfliet JJMC, et al
    Circulating fibroblast activation protein activity and antigen levels correlate strongly when measured in liver disease and coronary heart disease.
    PLoS One. 2017;12:e0178987.
    PubMed     Text format     Abstract available


  207. KRAUSKOPF J, de Kok TM, Schomaker SJ, Gosink M, et al
    Serum microRNA signatures as "liquid biopsies" for interrogating hepatotoxic mechanisms and liver pathogenesis in human.
    PLoS One. 2017;12:e0177928.
    PubMed     Text format     Abstract available


  208. WANG H, Zhang W, Gu H, Chen W, et al
    Identification and characterization of two linear epitope motifs in hepatitis E virus ORF2 protein.
    PLoS One. 2017;12:e0184947.
    PubMed     Text format     Abstract available


  209. HOU J, Brouwer WP, Kreefft K, Gama L, et al
    Unique intrahepatic transcriptomics profiles discriminate the clinical phases of a chronic HBV infection.
    PLoS One. 2017;12:e0179920.
    PubMed     Text format     Abstract available


  210. GONZALES-GUSTAVSON E, Timoneda N, Fernandez-Cassi X, Caballero A, et al
    Identification of sapovirus GV.2, astrovirus VA3 and novel anelloviruses in serum from patients with acute hepatitis of unknown aetiology.
    PLoS One. 2017;12:e0185911.
    PubMed     Text format     Abstract available


  211. NAGATY A, Abd El-Wahab EW
    Real-life results of sofosbuvir based therapy in chronic hepatitis C -naive and -experienced patients in Egypt.
    PLoS One. 2017;12:e0184654.
    PubMed     Text format     Abstract available


  212. NOSAKA T, Naito T, Hiramatsu K, Ohtani M, et al
    Gene expression profiling of hepatocarcinogenesis in a mouse model of chronic hepatitis B.
    PLoS One. 2017;12:e0185442.
    PubMed     Text format     Abstract available


  213. YANG CK, Wang XK, Liao XW, Han CY, et al
    Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinoma.
    PLoS One. 2017;12:e0182208.
    PubMed     Text format     Abstract available


  214. BIADGO B, Shiferaw E, Woldu B, Alene KA, et al
    Transfusion-transmissible viral infections among blood donors at the North Gondar district blood bank, northwest Ethiopia: A three year retrospective study.
    PLoS One. 2017;12:e0180416.
    PubMed     Text format     Abstract available


  215. PARASCHIV S, Banica L, Nicolae I, Niculescu I, et al
    Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users.
    PLoS One. 2017;12:e0185866.
    PubMed     Text format     Abstract available


  216. JARAMILLO CM, de La Hoz F, Porras A, di Filippo D, et al
    Characterization of hepatitis B virus in Amerindian children and mothers from Amazonas State, Colombia.
    PLoS One. 2017;12:e0181643.
    PubMed     Text format     Abstract available


  217. CHAMBAL LM, Samo Gudo E, Carimo A, Corte Real R, et al
    HBV infection in untreated HIV-infected adults in Maputo, Mozambique.
    PLoS One. 2017;12:e0181836.
    PubMed     Text format     Abstract available


  218. VAN LOO IHM, Dukers-Muijrers NHTM, Heuts R, van der Sande MAB, et al
    Screening for HIV, hepatitis B and syphilis on dried blood spots: A promising method to better reach hidden high-risk populations with self-collected sampling.
    PLoS One. 2017;12:e0186722.
    PubMed     Text format     Abstract available


  219. UEMURA H, Tsukada K, Mizushima D, Aoki T, et al
    Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders.
    PLoS One. 2017;12:e0186255.
    PubMed     Text format     Abstract available


  220. BURCHILL MA, Roby JA, Crochet N, Wind-Rotolo M, et al
    Rapid reversal of innate immune dysregulation in blood of patients and livers of humanized mice with HCV following DAA therapy.
    PLoS One. 2017;12:e0186213.
    PubMed     Text format     Abstract available


  221. LEE YL, Lin KY, Cheng CY, Li CW, et al
    Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan.
    PLoS One. 2017;12:e0186338.
    PubMed     Text format     Abstract available


  222. LY HJ, Lokugamage N, Nishiyama S, Ikegami T, et al
    Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
    PLoS One. 2017;12:e0185194.
    PubMed     Text format     Abstract available


  223. LI T, Gao Y, Dong Q, Wang H, et al
    Degree sums and dense spanning trees.
    PLoS One. 2017;12:e0184912.
    PubMed     Text format     Abstract available


  224. DUFFY D, Mottez E, Ainsworth S, Buivan TP, et al
    An in vitro diagnostic certified point of care single nucleotide test for IL28B polymorphisms.
    PLoS One. 2017;12:e0183084.
    PubMed     Text format     Abstract available


  225. LUBYOVA B, Hodek J, Zabransky A, Prouzova H, et al
    PRMT5: A novel regulator of Hepatitis B virus replication and an arginine methylase of HBV core.
    PLoS One. 2017;12:e0186982.
    PubMed     Text format     Abstract available


  226. CHEN YI MEI SLG, Thompson AJ, Christensen B, Cunningham G, et al
    Sustained virological response halts fibrosis progression: A long-term follow-up study of people with chronic hepatitis C infection.
    PLoS One. 2017;12:e0185609.
    PubMed     Text format     Abstract available


  227. YOON JG, Choi MJ, Yoon JW, Noh JY, et al
    Seroprevalence and disease burden of acute hepatitis A in adult population in South Korea.
    PLoS One. 2017;12:e0186257.
    PubMed     Text format     Abstract available


  228. PALIWAL D, Joshi P, Panda SK
    Hepatitis E Virus (HEV) egress: Role of BST2 (Tetherin) and interferon induced long non- coding RNA (lncRNA) BISPR.
    PLoS One. 2017;12:e0187334.
    PubMed     Text format     Abstract available


  229. OKA S, Furukawa H, Yasunami M, Kawasaki A, et al
    HLA-DRB1 and DQB1 alleles in Japanese type 1 autoimmune hepatitis: The predisposing role of the DR4/DR8 heterozygous genotype.
    PLoS One. 2017;12:e0187325.
    PubMed     Text format     Abstract available


  230. DULTZ G, Graubard BI, Martin P, Welker MW, et al
    Liver transplantation for chronic hepatitis C virus infection in the United States 2002-2014: An analysis of the UNOS/OPTN registry.
    PLoS One. 2017;12:e0186898.
    PubMed     Text format     Abstract available


  231. HARFOUCHE M, Chemaitelly H, Kouyoumjian SP, Mahmud S, et al
    Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta-analyses, and meta-regressions.
    PLoS One. 2017;12:e0187177.
    PubMed     Text format     Abstract available


  232. ROZERA G, Fabbri G, Lorenzini P, Mastrorosa I, et al
    Peripheral blood HIV-1 DNA dynamics in antiretroviral-treated HIV/HCV co-infected patients receiving directly-acting antivirals.
    PLoS One. 2017;12:e0187095.
    PubMed     Text format     Abstract available


  233. MAROT A, Henrion J, Knebel JF, Moreno C, et al
    Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.
    PLoS One. 2017;12:e0186715.
    PubMed     Text format     Abstract available


  234. KONDILI LA, Gaeta GB, Brunetto MR, Di Leo A, et al
    Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network.
    PLoS One. 2017;12:e0185728.
    PubMed     Text format     Abstract available


  235. LOGGI E, Galli S, Vitale G, Di Donato R, et al
    Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods.
    PLoS One. 2017;12:e0187755.
    PubMed     Text format     Abstract available


  236. LANINI S, Minosse C, Vairo F, Garbuglia A, et al
    A large ongoing outbreak of hepatitis A predominantly affecting young males in Lazio, Italy; August 2016 - March 2017.
    PLoS One. 2017;12:e0185428.
    PubMed     Text format     Abstract available


  237. YOSHIOKA N, Deguchi M, Hagiya H, Kagita M, et al
    Durability of immunity by hepatitis B vaccine in Japanese health care workers depends on primary response titers and durations.
    PLoS One. 2017;12:e0187661.
    PubMed     Text format     Abstract available


  238. YANG Z, Jia M, Liu G, Hao H, et al
    Genomic sequencing identifies a few mutations driving the independent origin of primary liver tumors in a chronic hepatitis murine model.
    PLoS One. 2017;12:e0187551.
    PubMed     Text format     Abstract available


  239. RISALDE MA, Rivero-Juarez A, Romero-Palomo F, Frias M, et al
    Persistence of hepatitis E virus in the liver of non-viremic naturally infected wild boar.
    PLoS One. 2017;12:e0186858.
    PubMed     Text format     Abstract available


  240. KONERMAN MA, Lu D, Zhang Y, Thomson M, et al
    Assessing risk of fibrosis progression and liver-related clinical outcomes among patients with both early stage and advanced chronic hepatitis C.
    PLoS One. 2017;12:e0187344.
    PubMed     Text format     Abstract available


  241. XIAO H, Shi M, Xie Y, Chi X, et al
    Comparison of diagnostic accuracy of magnetic resonance elastography and Fibroscan for detecting liver fibrosis in chronic hepatitis B patients: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0186660.
    PubMed     Text format     Abstract available


  242. YINDOM LM, Mendy M, Bodimeade C, Chambion C, et al
    KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians.
    PLoS One. 2017;12:e0188307.
    PubMed     Text format     Abstract available


  243. YANG A, Guo Z, Ren Q, Wu L, et al
    Active immunization in patients transplanted for hepatitis B virus related liver diseases: A prospective study.
    PLoS One. 2017;12:e0188190.
    PubMed     Text format     Abstract available


  244. SHIMIZU JF, Pereira CM, Bittar C, Batista MN, et al
    Multiple effects of toxins isolated from Crotalus durissus terrificus on the hepatitis C virus life cycle.
    PLoS One. 2017;12:e0187857.
    PubMed     Text format     Abstract available


  245. STROFFOLINI T, Sagnelli E, Andriulli A, Colloredo G, et al
    Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis.
    PLoS One. 2017;12:e0185710.
    PubMed     Text format     Abstract available


  246. GARRIGA C, Manzanares-Laya S, Garcia de Olalla P, Gorrindo P, et al
    Evolution of acute hepatitis C virus infection in a large European city: Trends and new patterns.
    PLoS One. 2017;12:e0187893.
    PubMed     Text format     Abstract available


  247. CARLUCCI JG, Farooq SA, Sizemore L, Rickles M, et al
    Low hepatitis C antibody screening rates among an insured population of Tennessean Baby Boomers.
    PLoS One. 2017;12:e0188624.
    PubMed     Text format     Abstract available


  248. BRAGA ACS, Carneiro BM, Batista MN, Akinaga MM, et al
    Heat shock proteins HSPB8 and DNAJC5B have HCV antiviral activity.
    PLoS One. 2017;12:e0188467.
    PubMed     Text format     Abstract available


  249. SPINA A, Lenglet A, Beversluis D, de Jong M, et al
    A large outbreak of Hepatitis E virus genotype 1 infection in an urban setting in Chad likely linked to household level transmission factors, 2016-2017.
    PLoS One. 2017;12:e0188240.
    PubMed     Text format     Abstract available


  250. LEE IC, Chau GY, Yeh YC, Chao Y, et al
    Risk of recurrence in chronic hepatitis B patients developing hepatocellular carcinoma with antiviral secondary prevention failure.
    PLoS One. 2017;12:e0188552.
    PubMed     Text format     Abstract available


  251. LIM J, Kim K, Choi S, Park SM, et al
    The effectiveness and limitation of the national childhood hepatitis A vaccination program in the Republic of Korea: Findings from the Korean National Health and Nutrition Examination Survey (KNHANES), 2015.
    PLoS One. 2017;12:e0189210.
    PubMed     Text format     Abstract available


  252. MUNSHI SU, Tran TTT, Vo TNT, Tabassum S, et al
    Molecular characterization of hepatitis B virus in Bangladesh reveals a highly recombinant population.
    PLoS One. 2017;12:e0188944.
    PubMed     Text format     Abstract available


  253. CANGELOSI Q, Means SA, Ho H
    A multi-scale spatial model of hepatitis-B viral dynamics.
    PLoS One. 2017;12:e0188209.
    PubMed     Text format     Abstract available


  254. CANINI L, Imamura M, Kawakami Y, Uprichard SL, et al
    HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients.
    PLoS One. 2017;12:e0187409.
    PubMed     Text format     Abstract available


  255. SMITH JW, Kroker-Lobos MF, Lazo M, Rivera-Andrade A, et al
    Aflatoxin and viral hepatitis exposures in Guatemala: Molecular biomarkers reveal a unique profile of risk factors in a region of high liver cancer incidence.
    PLoS One. 2017;12:e0189255.
    PubMed     Text format     Abstract available


  256. COMSTOCK E, Kim CW, Murphy A, Emmanuel B, et al
    Transcriptional profiling of PBMCs unravels B cell mediated immunopathogenic imprints of HCV vasculitis.
    PLoS One. 2017;12:e0188314.
    PubMed     Text format     Abstract available


  257. YIN F, Xie Y, Fan H, Zhang J, et al
    Mutations in hepatitis B virus polymerase are associated with the postoperative survival of hepatocellular carcinoma patients.
    PLoS One. 2017;12:e0189730.
    PubMed     Text format     Abstract available


  258. PANNETIER J, Gigonzac V, Lydie N, Desgrees du Lou A, et al
    Timing of chronic hepatitis B diagnosis after migration and its determinants among Sub-Saharan African migrants living in France.
    PLoS One. 2017;12:e0189196.
    PubMed     Text format     Abstract available


  259. DERESSA T, Damtie D, Fonseca K, Gao S, et al
    The burden of hepatitis B virus (HBV) infection, genotypes and drug resistance mutations in human immunodeficiency virus-positive patients in Northwest Ethiopia.
    PLoS One. 2017;12:e0190149.
    PubMed     Text format     Abstract available


  260. BROQUETAS T, Garcia-Retortillo M, Hernandez JJ, Puigvehi M, et al
    Quantification of HBsAg to predict low levels and seroclearance in HBeAg-negative patients receiving nucleos(t)ide analogues.
    PLoS One. 2017;12:e0188303.
    PubMed     Text format     Abstract available


  261. LAY P, An S, Soeung S, Srey PS, et al
    Ten year experience with antiretroviral treatment in Cambodia: Trends in patient characteristics and treatment outcomes.
    PLoS One. 2017;12:e0185348.
    PubMed     Text format     Abstract available


    January 2016
  262. GONZALEZ-ALDACO K, Rebello Pinho JR, Roman S, Gleyzer K, et al
    Association with Spontaneous Hepatitis C Viral Clearance and Genetic Differentiation of IL28B/IFNL4 Haplotypes in Populations from Mexico.
    PLoS One. 2016;11:e0146258.
    PubMed     Text format     Abstract available


  263. HANDISURYA A, Kerscher C, Tura A, Herkner H, et al
    Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.
    PLoS One. 2016;11:e0145319.
    PubMed     Text format     Abstract available


  264. BRANCHE E, Conzelmann S, Parisot C, Bedert L, et al
    Hepatitis C Virus Increases Occludin Expression via the Upregulation of Adipose Differentiation-Related Protein.
    PLoS One. 2016;11:e0146000.
    PubMed     Text format     Abstract available


  265. SASAKI R, Kanda T, Nakamura M, Nakamoto S, et al
    Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate Cells.
    PLoS One. 2016;11:e0146314.
    PubMed     Text format     Abstract available


  266. ULITZKY L, Lafer MM, KuKuruga MA, Silberstein E, et al
    A New Signaling Pathway for HCV Inhibition by Estrogen: GPR30 Activation Leads to Cleavage of Occludin by MMP-9.
    PLoS One. 2016;11:e0145212.
    PubMed     Text format     Abstract available


  267. DU H, Zhang S, Song M, Wang Y, et al
    Assessment of a Flavone-Polysaccharide Based Prescription for Treating Duck Virus Hepatitis.
    PLoS One. 2016;11:e0146046.
    PubMed     Text format     Abstract available


  268. CHEN QW, Li HJ, Chen YN, Ning ZY, et al
    Hepatic Lesions Detected after Mastectomy, in Breast Cancer Patients with Hepatitis Background May Need to Undergo Liver Biopsy to Rule Out Second Primary Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0139782.
    PubMed     Text format     Abstract available


  269. KONGKAVITOON P, Tangkijvanich P, Hirankarn N, Palaga T, et al
    Hepatitis B Virus HBx Activates Notch Signaling via Delta-Like 4/Notch1 in Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0146696.
    PubMed     Text format     Abstract available


  270. CHEN R, Kobewka M, Addison W, Lachance G, et al
    Intrinsic Viral Factors Are the Dominant Determinants of the Hepatitis C Virus Response to Interferon Alpha Treatment in Chimeric Mice.
    PLoS One. 2016;11:e0147007.
    PubMed     Text format     Abstract available


  271. BIVIGOU-MBOUMBA B, Francois-Souquiere S, Deleplancque L, Sica J, et al
    Broad Range of Hepatitis B Virus (HBV) Patterns, Dual Circulation of Quasi-Subgenotype A3 and HBV/E and Heterogeneous HBV Mutations in HIV-Positive Patients in Gabon.
    PLoS One. 2016;11:e0143869.
    PubMed     Text format     Abstract available


  272. WEDEMEYER H, Forns X, Hezode C, Lee SS, et al
    Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies.
    PLoS One. 2016;11:e0145409.
    PubMed     Text format     Abstract available


  273. MOON JS, Lee SH, Kim EJ, Cho H, et al
    Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot.
    PLoS One. 2016;11:e0146710.
    PubMed     Text format     Abstract available


  274. SINGH S, Vedi S, Samrat SK, Li W, et al
    Heterologous Immunity between Adenoviruses and Hepatitis C Virus: A New Paradigm in HCV Immunity and Vaccines.
    PLoS One. 2016;11:e0146404.
    PubMed     Text format     Abstract available


  275. LIU Y, Zhang L, Zhou JY, Pan J, et al
    Clinical and Virological Characteristics of Chronic Hepatitis B Patients with Coexistence of HBsAg and Anti-HBs.
    PLoS One. 2016;11:e0146980.
    PubMed     Text format     Abstract available


  276. LITTERA R, Chessa L, Onali S, Figorilli F, et al
    Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis.
    PLoS One. 2016;11:e0146086.
    PubMed     Text format     Abstract available


  277. JIANG L, Wu X, He F, Liu Y, et al
    Genetic Evidence for Genotoxic Effect of Entecavir, an Anti-Hepatitis B Virus Nucleotide Analog.
    PLoS One. 2016;11:e0147440.
    PubMed     Text format     Abstract available


  278. GUPTA G, Song J
    C-Terminal Auto-Regulatory Motif of Hepatitis C Virus NS5B Interacts with Human VAPB-MSP to Form a Dynamic Replication Complex.
    PLoS One. 2016;11:e0147278.
    PubMed     Text format     Abstract available


  279. KILPATRICK S, Dreistadt M, Frowde P, Powell R, et al
    Presence of Systemic Inflammatory Response Syndrome Predicts a Poor Clinical Outcome in Dogs with a Primary Hepatitis.
    PLoS One. 2016;11:e0146560.
    PubMed     Text format     Abstract available


  280. ZHAO Q, Wen Y, Jiang Y, Zhang C, et al
    Next Generation Sequencing-Based Investigation of Potential Patient-to-Patient Hepatitis C Virus Transmission during Hemodialytic Treatment.
    PLoS One. 2016;11:e0147566.
    PubMed     Text format     Abstract available


  281. LIU S, Zhao T, Song B, Zhou J, et al
    Comparative Proteomics Reveals Important Viral-Host Interactions in HCV-Infected Human Liver Cells.
    PLoS One. 2016;11:e0147991.
    PubMed     Text format     Abstract available


  282. ALDAMIZ-ECHEVARRIA T, Berenguer J, Miralles P, Jimenez-Sousa MA, et al
    Soluble Adhesion Molecules in Patients Coinfected with HIV and HCV: A Predictor of Outcome.
    PLoS One. 2016;11:e0148537.
    PubMed     Text format     Abstract available


  283. NEUKAM K, Mira JA, Collado A, Rivero-Juarez A, et al
    Liver Toxicity of Current Antiretroviral Regimens in HIV-Infected Patients with Chronic Viral Hepatitis in a Real-Life Setting: The HEPAVIR SEG-HEP Cohort.
    PLoS One. 2016;11:e0148104.
    PubMed     Text format     Abstract available


  284. WEI Y, Li J, Qing J, Huang M, et al
    Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking.
    PLoS One. 2016;11:e0148181.
    PubMed     Text format     Abstract available


  285. THOLEN AT, Schinkel J, Molenkamp R, Ang CW, et al
    Hepatitis E virus as a Cause of Acute Hepatitis in The Netherlands.
    PLoS One. 2016;11:e0146906.
    PubMed     Text format     Abstract available


  286. STINDT S, Cebula P, Albrecht U, Keitel V, et al
    Hepatitis C Virus Activates a Neuregulin-Driven Circuit to Modify Surface Expression of Growth Factor Receptors of the ErbB Family.
    PLoS One. 2016;11:e0148711.
    PubMed     Text format     Abstract available


  287. RENDON J, Hoyos MC, di Filippo D, Cortes-Mancera F, et al
    Hepatitis E Virus Genotype 3 in Colombia: Survey in Patients with Clinical Diagnosis of Viral Hepatitis.
    PLoS One. 2016;11:e0148417.
    PubMed     Text format     Abstract available


  288. WASITTHANKASEM R, Posuwan N, Vichaiwattana P, Theamboonlers A, et al
    Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey.
    PLoS One. 2016;11:e0149362.
    PubMed     Text format     Abstract available


  289. IZQUIERDO L, Oliveira C, Fournier C, Descamps V, et al
    Hepatitis C Virus Resistance to Carbohydrate-Binding Agents.
    PLoS One. 2016;11:e0149064.
    PubMed     Text format     Abstract available


  290. BRUNI R, Taffon S, Equestre M, Chionne P, et al
    Key Role of Sequencing to Trace Hepatitis A Viruses Circulating in Italy During a Large Multi-Country European Foodborne Outbreak in 2013.
    PLoS One. 2016;11:e0149642.
    PubMed     Text format     Abstract available


  291. HUNG IF, Wong DK, Poon RT, Fong DY, et al
    Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0148493.
    PubMed     Text format     Abstract available


  292. ROGAL SS, Arnold RM, Chapko M, Hanusa BV, et al
    The Patient-Provider Relationship Is Associated with Hepatitis C Treatment Eligibility: A Prospective Mixed-Methods Cohort Study.
    PLoS One. 2016;11:e0148596.
    PubMed     Text format     Abstract available


  293. CHAABNA K, Kouyoumjian SP, Abu-Raddad LJ
    Hepatitis C Virus Epidemiology in Djibouti, Somalia, Sudan, and Yemen: Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0149966.
    PubMed     Text format     Abstract available


  294. XIE B, Zhang P, Liu M, Zeng W, et al
    Deltex1 Polymorphisms Are Associated with Hepatitis B Vaccination Non-Response in Southwest China.
    PLoS One. 2016;11:e0149199.
    PubMed     Text format     Abstract available


  295. CARABALLO CORTES K, Zagordi O, Jablonska J, Pawelczyk A, et al
    Spouse-to-Spouse Transmission and Evolution of Hypervariable Region 1 and 5' Untranslated Region of Hepatitis C Virus Analyzed by Next-Generation Sequencing.
    PLoS One. 2016;11:e0150311.
    PubMed     Text format     Abstract available


  296. WANG C, Shi CX, Rou K, Zhao Y, et al
    Baseline HCV Antibody Prevalence and Risk Factors among Drug Users in China's National Methadone Maintenance Treatment Program.
    PLoS One. 2016;11:e0147922.
    PubMed     Text format     Abstract available


  297. WU CK, Chang KC, Tseng PL, Lu SN, et al
    Comparison of Therapeutic Response and Clinical Outcome between HCV Patients with Normal and Abnormal Alanine Transaminase Levels.
    PLoS One. 2016;11:e0142378.
    PubMed     Text format     Abstract available


  298. O'CONNELL S, Lillis D, Cotter A, O'Dea S, et al
    Opt-Out Panel Testing for HIV, Hepatitis B and Hepatitis C in an Urban Emergency Department: A Pilot Study.
    PLoS One. 2016;11:e0150546.
    PubMed     Text format     Abstract available


  299. BEAUMONT E, Roch E, Chopin L, Roingeard P, et al
    Hepatitis C Virus E1 and E2 Proteins Used as Separate Immunogens Induce Neutralizing Antibodies with Additive Properties.
    PLoS One. 2016;11:e0151626.
    PubMed     Text format     Abstract available


  300. TSAI MC, Chen CH, Tseng PL, Hung CH, et al
    Does Nucleos(t)ide Analogues Treatment Affect Renal Function in Chronic Hepatitis B Patients Who Have Already Decreased eGFR? A Longitudinal Study.
    PLoS One. 2016;11:e0149761.
    PubMed     Text format     Abstract available


  301. JANJUA NZ, Kuo M, Chong M, Yu A, et al
    Assessing Hepatitis C Burden and Treatment Effectiveness through the British Columbia Hepatitis Testers Cohort (BC-HTC): Design and Characteristics of Linked and Unlinked Participants.
    PLoS One. 2016;11:e0150176.
    PubMed     Text format     Abstract available


  302. REN JH, Chen X, Zhou L, Tao NN, et al
    Protective Role of Sirtuin3 (SIRT3) in Oxidative Stress Mediated by Hepatitis B Virus X Protein Expression.
    PLoS One. 2016;11:e0150961.
    PubMed     Text format     Abstract available


  303. YAO M, Lu X, Lei Y, Yang J, et al
    Conditional Inducible Triple-Transgenic Mouse Model for Rapid Real-Time Detection of HCV NS3/4A Protease Activity.
    PLoS One. 2016;11:e0150894.
    PubMed     Text format     Abstract available


  304. ZHUANG Y, Li Y, Li X, Xie Q, et al
    Atg7 Knockdown Augments Concanavalin A-Induced Acute Hepatitis through an ROS-Mediated p38/MAPK Pathway.
    PLoS One. 2016;11:e0149754.
    PubMed     Text format     Abstract available


  305. POSUWAN N, Wanlapakorn N, Sa-Nguanmoo P, Wasitthankasem R, et al
    The Success of a Universal Hepatitis B Immunization Program as Part of Thailand's EPI after 22 Years' Implementation.
    PLoS One. 2016;11:e0150499.
    PubMed     Text format     Abstract available


  306. SPINDELBOECK W, Horvath A, Tawdrous M, Schmerbock B, et al
    Triple Therapy with First Generation Protease Inhibitors for Hepatitis C Markedly Impairs Function of Neutrophil Granulocytes.
    PLoS One. 2016;11:e0150299.
    PubMed     Text format     Abstract available


  307. CHEN M, Wong WW, Law MG, Kiertiburanakul S, et al
    Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.
    PLoS One. 2016;11:e0150512.
    PubMed     Text format     Abstract available


  308. ASSELAH T, Thompson AJ, Flisiak R, Romero-Gomez M, et al
    A Predictive Model for Selecting Patients with HCV Genotype 3 Chronic Infection with a High Probability of Sustained Virological Response to Peginterferon Alfa-2a/Ribavirin.
    PLoS One. 2016;11:e0150569.
    PubMed     Text format     Abstract available


  309. MATSUMOTO N, Ikeda H, Shigefuku R, Hattori N, et al
    Hemoglobin Decrease with Iron Deficiency Induced by Daclatasvir plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b.
    PLoS One. 2016;11:e0151238.
    PubMed     Text format     Abstract available


  310. DIETZE KK, Schimmer S, Kretzmer F, Wang J, et al
    Characterization of the Treg Response in the Hepatitis B Virus Hydrodynamic Injection Mouse Model.
    PLoS One. 2016;11:e0151717.
    PubMed     Text format     Abstract available


  311. SA-NGUANMOO P, Posuwan N, Vichaiwattana P, Vuthitanachot V, et al
    Declining Trend of Hepatitis A Seroepidemiology in Association with Improved Public Health and Economic Status of Thailand.
    PLoS One. 2016;11:e0151304.
    PubMed     Text format     Abstract available


  312. TAWARA S, Tatsumi T, Iio S, Kobayashi I, et al
    Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C.
    PLoS One. 2016;11:e0151828.
    PubMed     Text format     Abstract available


  313. WANDELER G, Musukuma K, Zurcher S, Vinikoor MJ, et al
    Hepatitis B Infection, Viral Load and Resistance in HIV-Infected Patients in Mozambique and Zambia.
    PLoS One. 2016;11:e0152043.
    PubMed     Text format     Abstract available


  314. BAGHERI AMIRI F, Mostafavi E, Mirzazadeh A
    HIV, HBV and HCV Coinfection Prevalence in Iran - A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0151946.
    PubMed     Text format     Abstract available


  315. CHEN Y, Zhao Q, Liu B, Wang L, et al
    A Novel Blocking ELISA for Detection of Antibodies against Hepatitis E Virus in Domestic Pigs.
    PLoS One. 2016;11:e0152639.
    PubMed     Text format     Abstract available


  316. YU JS, Chen WC, Tseng CK, Lin CK, et al
    Sulforaphane Suppresses Hepatitis C Virus Replication by Up-Regulating Heme Oxygenase-1 Expression through PI3K/Nrf2 Pathway.
    PLoS One. 2016;11:e0152236.
    PubMed     Text format     Abstract available


  317. REN S, Wang J, Chen TL, Li HY, et al
    Hepatitis B Virus Stimulated Fibronectin Facilitates Viral Maintenance and Replication through Two Distinct Mechanisms.
    PLoS One. 2016;11:e0152721.
    PubMed     Text format     Abstract available


  318. FOSTER GR, Coppola C, Derbala M, Ferenci P, et al
    Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort.
    PLoS One. 2016;11:e0151703.
    PubMed     Text format     Abstract available


  319. ZHANG X, Bilic I, Marek A, Glosmann M, et al
    C-Terminal Amino Acids 471-507 of Avian Hepatitis E Virus Capsid Protein Are Crucial for Binding to Avian and Human Cells.
    PLoS One. 2016;11:e0153723.
    PubMed     Text format     Abstract available


  320. JI J, Wang H, Li Y, Zheng L, et al
    Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus alpha-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
    PLoS One. 2016;11:e0153227.
    PubMed     Text format     Abstract available


  321. SAID EA, Al-Reesi I, Al-Riyami M, Al-Naamani K, et al
    A Potential Inhibitory Profile of Liver CD68+ Cells during HCV Infection as Observed by an Increased CD80 and PD-L1 but Not CD86 Expression.
    PLoS One. 2016;11:e0153191.
    PubMed     Text format     Abstract available


  322. RIZK HH, Hamdy NM, Al-Ansari NL, El-Mesallamy HO, et al
    Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4.
    PLoS One. 2016;11:e0153895.
    PubMed     Text format     Abstract available


  323. RAJHI M, Ghedira K, Chouikha A, Djebbi A, et al
    Phylogenetic Analysis and Epidemic History of Hepatitis C Virus Genotype 2 in Tunisia, North Africa.
    PLoS One. 2016;11:e0153761.
    PubMed     Text format     Abstract available


  324. CHUECA N, Rivadulla I, Lovatti R, Reina G, et al
    Using NS5B Sequencing for Hepatitis C Virus Genotyping Reveals Discordances with Commercial Platforms.
    PLoS One. 2016;11:e0153754.
    PubMed     Text format     Abstract available


  325. WANG Z, Chen Y, Xie S, Lv H, et al
    Changing Epidemiological Characteristics of Hepatitis A in Zhejiang Province, China: Increased Susceptibility in Adults.
    PLoS One. 2016;11:e0153804.
    PubMed     Text format     Abstract available


  326. MACPARLAND SA, Fadel SM, Mihajlovic V, Fawaz A, et al
    HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.
    PLoS One. 2016;11:e0154433.
    PubMed     Text format     Abstract available


  327. GAO Y, Ren H, Meng F, Li J, et al
    Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.
    PLoS One. 2016;11:e0154419.
    PubMed     Text format     Abstract available


  328. RAMANATHAN A, Gusarova V, Stahl N, Gurnett-Bander A, et al
    Alirocumab, a Therapeutic Human Antibody to PCSK9, Does Not Affect CD81 Levels or Hepatitis C Virus Entry and Replication into Hepatocytes.
    PLoS One. 2016;11:e0154498.
    PubMed     Text format     Abstract available


  329. HAN Y, Niu J, Wang D, Li Y, et al
    Hepatitis C Virus Protein Interaction Network Analysis Based on Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0153882.
    PubMed     Text format     Abstract available


  330. GALLAY PA, Chatterji U, Bobardt MD, Long Z, et al
    Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175.
    PLoS One. 2016;11:e0152036.
    PubMed     Text format     Abstract available


  331. NGUYEN TRUONG T, Laureillard D, Lacombe K, Duong Thi H, et al
    High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262).
    PLoS One. 2016;11:e0153744.
    PubMed     Text format     Abstract available


  332. IBRAHIM MK, Salum GM, Bader El Din NG, Dawood RM, et al
    Transcriptional Dysregulation of Upstream Signaling of IFN Pathway in Chronic HCV Type 4 Induced Liver Fibrosis.
    PLoS One. 2016;11:e0154512.
    PubMed     Text format     Abstract available


  333. KUO YH, Tsai MC, Kee KM, Chang KC, et al
    Associated Factors for Metabolic Syndrome in the Older Adults with Chronic Virus Hepatitis in the Community.
    PLoS One. 2016;11:e0155544.
    PubMed     Text format     Abstract available


  334. WANG D, Chen TW, Zhang XM, Li J, et al
    Liver Lobe Based Multi-Echo Gradient Recalled Echo T2*-Weighted Imaging in Chronic Hepatitis B-Related Cirrhosis: Association with the Presence and Child-Pugh Class of Cirrhosis.
    PLoS One. 2016;11:e0154545.
    PubMed     Text format     Abstract available


  335. WALDENSTROM J, Westin J, Nystrom K, Christensen P, et al
    Randomized Trial Evaluating the Impact of Ribavirin Mono-Therapy and Double Dosing on Viral Kinetics, Ribavirin Pharmacokinetics and Anemia in Hepatitis C Virus Genotype 1 Infection.
    PLoS One. 2016;11:e0155142.
    PubMed     Text format     Abstract available


  336. GRANADOS-GARCIA V, Contreras AM, Garcia-Pena C, Salinas-Escudero G, et al
    Cost-Effectiveness Analysis of Different Testing Strategies that Use Antibody Levels to Detect Chronic Hepatitis C in Blood Donors.
    PLoS One. 2016;11:e0154625.
    PubMed     Text format     Abstract available


  337. EMBADE N, Marino Z, Diercks T, Cano A, et al
    Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum 1H-NMR Spectroscopy.
    PLoS One. 2016;11:e0155094.
    PubMed     Text format     Abstract available


  338. KALAGHATGI P, Sikorski AM, Knops E, Rupp D, et al
    Geno2pheno[HCV] - A Web-based Interpretation System to Support Hepatitis C Treatment Decisions in the Era of Direct-Acting Antiviral Agents.
    PLoS One. 2016;11:e0155869.
    PubMed     Text format     Abstract available


  339. NEUKAM K, Espinosa N, Collado A, Delgado-Fernandez M, et al
    Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study.
    PLoS One. 2016;11:e0155842.
    PubMed     Text format     Abstract available


  340. WASITTHANKASEM R, Posuwan N, Vichaiwattana P, Theamboonlers A, et al
    Correction: Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey.
    PLoS One. 2016;11:e0152451.
    PubMed     Text format     Abstract available


  341. CHEN J, Liu Y, Zhao J, Xu Z, et al
    Characterization of Novel Hepatitis B Virus PreS/S-Gene Mutations in a Patient with Occult Hepatitis B Virus Infection.
    PLoS One. 2016;11:e0155654.
    PubMed     Text format     Abstract available


  342. YANG L, Yang X, Kong X, Cao Z, et al
    Covariation Analysis of Serumal and Urinary Metabolites Suggests Aberrant Glycine and Fatty Acid Metabolism in Chronic Hepatitis B.
    PLoS One. 2016;11:e0156166.
    PubMed     Text format     Abstract available


  343. BERTISCH B, Giudici F, Negro F, Moradpour D, et al
    Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations.
    PLoS One. 2016;11:e0155464.
    PubMed     Text format     Abstract available


  344. STONE J, Martin NK, Hickman M, Hellard M, et al
    The Potential Impact of a Hepatitis C Vaccine for People Who Inject Drugs: Is a Vaccine Needed in the Age of Direct-Acting Antivirals?
    PLoS One. 2016;11:e0156213.
    PubMed     Text format     Abstract available


  345. AMORAS EDA S, Gomes ST, Freitas FB, Santana BB, et al
    Intrahepatic mRNA Expression of FAS, FASL, and FOXP3 Genes Is Associated with the Pathophysiology of Chronic HCV Infection.
    PLoS One. 2016;11:e0156604.
    PubMed     Text format     Abstract available


  346. DIETZ J, Rupp D, Susser S, Vermehren J, et al
    Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy.
    PLoS One. 2016;11:e0156731.
    PubMed     Text format     Abstract available


  347. ASPORD C, Bruder Costa J, Jacob MC, Dufeu-Duchesne T, et al
    Remodeling of B-Cell Subsets in Blood during Pegylated IFNalpha-2a Therapy in Patients with Chronic Hepatitis B Infection.
    PLoS One. 2016;11:e0156200.
    PubMed     Text format     Abstract available


  348. KLUSHKINA VV, Kyuregyan KK, Kozhanova TV, Popova OE, et al
    Impact of Universal Hepatitis B Vaccination on Prevalence, Infection-Associated Morbidity and Mortality, and Circulation of Immune Escape Variants in Russia.
    PLoS One. 2016;11:e0157161.
    PubMed     Text format     Abstract available


  349. SILBERSTEIN E, Ulitzky L, Lima LA, Cehan N, et al
    HCV-Mediated Apoptosis of Hepatocytes in Culture and Viral Pathogenesis.
    PLoS One. 2016;11:e0155708.
    PubMed     Text format     Abstract available


  350. LIN SY, Toyoda H, Kumada T, Liu HF, et al
    Molecular Evolution and Phylodynamics of Acute Hepatitis B Virus in Japan.
    PLoS One. 2016;11:e0157103.
    PubMed     Text format     Abstract available


  351. NARAYANAN S, Nieh AH, Kenwood BM, Davis CA, et al
    Distinct Roles for Intracellular and Extracellular Lipids in Hepatitis C Virus Infection.
    PLoS One. 2016;11:e0156996.
    PubMed     Text format     Abstract available


  352. CHEN GF, Wei L, Chen J, Duan ZP, et al
    Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data.
    PLoS One. 2016;11:e0155934.
    PubMed     Text format     Abstract available


  353. CHIU KW, Nakano T, Chen KD, Lin CC, et al
    Association of IL28B SNPs rs12979860 and rs8099917 on Hepatitis C Virus-RNA Status in Donors/Recipients of Living Donor Liver Transplantation.
    PLoS One. 2016;11:e0156846.
    PubMed     Text format     Abstract available


  354. AMPAH KA, Pinho-Nascimento CA, Kerber S, Asare P, et al
    Limited Genetic Diversity of Hepatitis B Virus in the General Population of the Offin River Valley in Ghana.
    PLoS One. 2016;11:e0156864.
    PubMed     Text format     Abstract available


  355. WEI W, Jiang J, Liang H, Gao L, et al
    Application of a Combined Model with Autoregressive Integrated Moving Average (ARIMA) and Generalized Regression Neural Network (GRNN) in Forecasting Hepatitis Incidence in Heng County, China.
    PLoS One. 2016;11:e0156768.
    PubMed     Text format     Abstract available


  356. CANIONI D, Michot JM, Rabiega P, Molina TJ, et al
    In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas.
    PLoS One. 2016;11:e0156384.
    PubMed     Text format     Abstract available


  357. AL-MAHTAB M, Bazinet M, Vaillant A
    Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection.
    PLoS One. 2016;11:e0156667.
    PubMed     Text format     Abstract available


  358. LUO X, Huang Y, Chen Y, Tu Z, et al
    Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0157708.
    PubMed     Text format     Abstract available


  359. VERNAZ N, Girardin F, Goossens N, Brugger U, et al
    Drug Pricing Evolution in Hepatitis C.
    PLoS One. 2016;11:e0157098.
    PubMed     Text format     Abstract available


  360. HUIK K, Avi R, Pauskar M, Kallas E, et al
    A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs.
    PLoS One. 2016;11:e0156850.
    PubMed     Text format     Abstract available


  361. D'AMBROSIO R, Degasperi E, Aghemo A, Fraquelli M, et al
    Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon.
    PLoS One. 2016;11:e0155967.
    PubMed     Text format     Abstract available


  362. KIM YI, Kim HS, Park JW
    Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase.
    PLoS One. 2016;11:e0157299.
    PubMed     Text format     Abstract available


  363. ROUX P, Rojas Castro D, Ndiaye K, Debrus M, et al
    Increased Uptake of HCV Testing through a Community-Based Educational Intervention in Difficult-to-Reach People Who Inject Drugs: Results from the ANRS-AERLI Study.
    PLoS One. 2016;11:e0157062.
    PubMed     Text format     Abstract available


  364. BURKE SCHINKEL SC, Carrasco-Medina L, Cooper CL, Crawley AM, et al
    Generalized Liver- and Blood-Derived CD8+ T-Cell Impairment in Response to Cytokines in Chronic Hepatitis C Virus Infection.
    PLoS One. 2016;11:e0157055.
    PubMed     Text format     Abstract available


  365. DOYLE JS, Grebely J, Spelman T, Alavi M, et al
    Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort.
    PLoS One. 2016;11:e0150655.
    PubMed     Text format     Abstract available


  366. ZHOU K, Liang Z, Wang C, Hu F, et al
    Natural Polymorphisms Conferring Resistance to HCV Protease and Polymerase Inhibitors in Treatment-Naive HIV/HCV Co-Infected Patients in China.
    PLoS One. 2016;11:e0157438.
    PubMed     Text format     Abstract available


  367. KUNTZEN T, Kuhn S, Kuntzen D, Seifert B, et al
    Influence of Ribavirin Serum Levels on Outcome of Antiviral Treatment and Anemia in Hepatitis C Virus Infection.
    PLoS One. 2016;11:e0158512.
    PubMed     Text format     Abstract available


  368. HUANG L, Liu C, Deng Y, Liu Y, et al
    Association of Hypoxia-Inducible Factor-2 Alpha Gene Polymorphisms with the Risk of Hepatitis B Virus-Related Liver Disease in Guangxi Chinese: A Case-Control Study.
    PLoS One. 2016;11:e0158241.
    PubMed     Text format     Abstract available


  369. GLAVIND E, Aagaard NK, Gronbaek H, Moller HJ, et al
    Alcoholic Hepatitis Markedly Decreases the Capacity for Urea Synthesis.
    PLoS One. 2016;11:e0158388.
    PubMed     Text format     Abstract available


  370. HOMS M, Rodriguez-Frias F, Gregori J, Ruiz A, et al
    Evidence of an Exponential Decay Pattern of the Hepatitis Delta Virus Evolution Rate and Fluctuations in Quasispecies Complexity in Long-Term Studies of Chronic Delta Infection.
    PLoS One. 2016;11:e0158557.
    PubMed     Text format     Abstract available


  371. SHI L, Qin E, Zhou J, Zhao J, et al
    HIV and HCV Co-Culture Promotes Profibrogenic Gene Expression through an Epimorphin-Mediated ERK Signaling Pathway in Hepatic Stellate Cells.
    PLoS One. 2016;11:e0158386.
    PubMed     Text format     Abstract available


  372. MLUNDE LB, Sunguya BF, Mbwambo JK, Ubuguyu OS, et al
    A Mismatch between High-Risk Behaviors and Screening of Infectious Diseases among People Who Inject Drugs in Dar es Salaam, Tanzania.
    PLoS One. 2016;11:e0148598.
    PubMed     Text format     Abstract available


  373. MUNYUA PM, Murithi RM, Ithondeka P, Hightower A, et al
    Predictive Factors and Risk Mapping for Rift Valley Fever Epidemics in Kenya.
    PLoS One. 2016;11:e0144570.
    PubMed     Text format     Abstract available


  374. MAEDA Y, Migita K, Higuchi O, Mukaino A, et al
    Association between Anti-Ganglionic Nicotinic Acetylcholine Receptor (gAChR) Antibodies and HLA-DRB1 Alleles in the Japanese Population.
    PLoS One. 2016;11:e0146048.
    PubMed     Text format     Abstract available


  375. MAOR Y, Malnick SD, Melzer E, Leshno M, et al
    Treatment of Chronic Hepatitis C in the Aged - Does It Impact Life Expectancy? A Decision Analysis.
    PLoS One. 2016;11:e0157832.
    PubMed     Text format     Abstract available


  376. PARK SB, Seronello S, Mayer W, Ojcius DM, et al
    Hepatitis C Virus Frameshift/Alternate Reading Frame Protein Suppresses Interferon Responses Mediated by Pattern Recognition Receptor Retinoic-Acid-Inducible Gene-I.
    PLoS One. 2016;11:e0158419.
    PubMed     Text format     Abstract available


  377. LI YX, Ren YL, Fu HJ, Zou L, et al
    Hepatitis B Virus Middle Protein Enhances IL-6 Production via p38 MAPK/NF-kappaB Pathways in an ER Stress-Dependent Manner.
    PLoS One. 2016;11:e0159089.
    PubMed     Text format     Abstract available


  378. RODRIGO MB, Mojsiejczuk LN, Torres C, Sevic I, et al
    Analysis of the Molecular Evolution of Hepatitis B Virus Genotypes in Symptomatic Acute Infections in Argentina.
    PLoS One. 2016;11:e0159509.
    PubMed     Text format     Abstract available


  379. ASSELAH T, Moreno C, Sarrazin C, Gschwantler M, et al
    An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naive Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1).
    PLoS One. 2016;11:e0158526.
    PubMed     Text format     Abstract available


  380. SPAAN M, Hullegie SJ, Beudeker BJ, Kreefft K, et al
    Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy.
    PLoS One. 2016;11:e0159243.
    PubMed     Text format     Abstract available


  381. LIN MV, Sise ME, Pavlakis M, Amundsen BM, et al
    Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.
    PLoS One. 2016;11:e0158431.
    PubMed     Text format     Abstract available


  382. YAN L, Qu S, Liu G, Liu L, et al
    Comparative Transcriptomic Analysis of Primary Duck Hepatocytes Provides Insight into Differential Susceptibility to DHBV Infection.
    PLoS One. 2016;11:e0149702.
    PubMed     Text format     Abstract available


  383. GILES DA, Moreno-Fernandez ME, Stankiewicz TE, Cappelletti M, et al
    Regulation of Inflammation by IL-17A and IL-17F Modulates Non-Alcoholic Fatty Liver Disease Pathogenesis.
    PLoS One. 2016;11:e0149783.
    PubMed     Text format     Abstract available


  384. HUANG W, Zhang H, Hao Y, Xu X, et al
    A Non-Synonymous Single Nucleotide Polymorphism in the HJURP Gene Associated with Susceptibility to Hepatocellular Carcinoma among Chinese.
    PLoS One. 2016;11:e0148618.
    PubMed     Text format     Abstract available


  385. AZEVEDO E SILVA G, de Moura L, Curado MP, Gomes Fda S, et al
    The Fraction of Cancer Attributable to Ways of Life, Infections, Occupation, and Environmental Agents in Brazil in 2020.
    PLoS One. 2016;11:e0148761.
    PubMed     Text format     Abstract available


  386. CONRAD KD, Giering F, Erfurth C, Neumann A, et al
    Correction: microRNA-122 Dependent Binding of Ago2 Protein to Hepatitis C Virus RNA Is Associated with Enhanced RNA Stability and Translation Stimulation.
    PLoS One. 2016;11:e0160132.
    PubMed     Text format     Abstract available


  387. STAHMEYER JT, Rossol S, Bert F, Boker KH, et al
    Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors - Results from the PAN Study.
    PLoS One. 2016;11:e0159976.
    PubMed     Text format     Abstract available


  388. DEBES JD, Martinez Wassaf M, Pisano MB, Isa MB, et al
    Increased Hepatitis E Virus Seroprevalence Correlates with Lower CD4+ Cell Counts in HIV-Infected Persons in Argentina.
    PLoS One. 2016;11:e0160082.
    PubMed     Text format     Abstract available


  389. IWASA S, Sato N, Wang CW, Cheng YH, et al
    The Phospholipid:Diacylglycerol Acyltransferase Lro1 Is Responsible for Hepatitis C Virus Core-Induced Lipid Droplet Formation in a Yeast Model System.
    PLoS One. 2016;11:e0159324.
    PubMed     Text format     Abstract available


  390. ZHANG YH, Zhao Y, Rajapaksa US, Lawrence TM, et al
    A Comprehensive Analysis of the Impact of HIV on HCV Immune Responses and Its Association with Liver Disease Progression in a Unique Plasma Donor Cohort.
    PLoS One. 2016;11:e0158037.
    PubMed     Text format     Abstract available


  391. KONG FY, Wei X, Zhou K, Hu W, et al
    Bioinformatics Analysis Reveals Distinct Molecular Characteristics of Hepatitis B-Related Hepatocellular Carcinomas from Very Early to Advanced Barcelona Clinic Liver Cancer Stages.
    PLoS One. 2016;11:e0158286.
    PubMed     Text format     Abstract available


  392. CHATTERJI U, Bobardt M, Schaffer L, Wood M, et al
    Cyclophilin Inhibitors Remodel the Endoplasmic Reticulum of HCV-Infected Cells in a Unique Pattern Rendering Cells Impervious to a Reinfection.
    PLoS One. 2016;11:e0159511.
    PubMed     Text format     Abstract available


  393. CHEKURI S, Nickerson J, Bichoupan K, Sefcik R, et al
    Liver Stiffness Decreases Rapidly in Response to Successful Hepatitis C Treatment and Then Plateaus.
    PLoS One. 2016;11:e0159413.
    PubMed     Text format     Abstract available


  394. ELHEFNAWI M, Kim T, Kamar MA, Min S, et al
    In Silico Design and Experimental Validation of siRNAs Targeting Conserved Regions of Multiple Hepatitis C Virus Genotypes.
    PLoS One. 2016;11:e0159211.
    PubMed     Text format     Abstract available


  395. SOLOMON SS, Srikrishnan AK, McFall AM, Kumar MS, et al
    Burden of Liver Disease among Community-Based People Who Inject Drugs (PWID) in Chennai, India.
    PLoS One. 2016;11:e0147879.
    PubMed     Text format     Abstract available


  396. LAUGHLIN RC, Drake KL, Morrill JC, Adams LG, et al
    Correlative Gene Expression to Protective Seroconversion in Rift Valley Fever Vaccinates.
    PLoS One. 2016;11:e0147027.
    PubMed     Text format     Abstract available


  397. ZHANG QF, Shao JY, Yin WW, Xia Y, et al
    Altered Immune Profiles of Natural Killer Cells in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0160171.
    PubMed     Text format     Abstract available


  398. OLIVEIRA MP, Matos MA, Silva AM, Lopes CL, et al
    Prevalence, Risk Behaviors, and Virological Characteristics of Hepatitis B Virus Infection in a Group of Men Who Have Sex with Men in Brazil: Results from a Respondent-Driven Sampling Survey.
    PLoS One. 2016;11:e0160916.
    PubMed     Text format     Abstract available


  399. HSIAO PJ, Hsieh PF, Chou EC, Lai HC, et al
    Anti-Viral Therapy and Decreased Sexual Desire in Patients with Chronic Hepatitis C.
    PLoS One. 2016;11:e0160450.
    PubMed     Text format     Abstract available


  400. KLIEMANN DA, Tovo CV, Gorini da Veiga AB, Machado AL, et al
    Genetic Barrier to Direct Acting Antivirals in HCV Sequences Deposited in the European Databank.
    PLoS One. 2016;11:e0159924.
    PubMed     Text format     Abstract available


  401. BERGER KL, Sarrazin C, Nelson DR, Scherer J, et al
    Resistance Analyses of HCV NS3/4A Protease and NS5B Polymerase from Clinical Studies of Deleobuvir and Faldaprevir.
    PLoS One. 2016;11:e0160668.
    PubMed     Text format     Abstract available


  402. OKPECHI IG, Ameh OI, Bello AK, Ronco P, et al
    Epidemiology of Histologically Proven Glomerulonephritis in Africa: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0152203.
    PubMed     Text format     Abstract available


  403. CHANG TS, Chen CL, Wu YC, Liu JJ, et al
    Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0149897.
    PubMed     Text format     Abstract available


  404. VAN DER AA E, Buschow SI, Biesta PJ, Janssen HL, et al
    The Effect of Chronic Hepatitis B Virus Infection on BDCA3+ Dendritic Cell Frequency and Function.
    PLoS One. 2016;11:e0161235.
    PubMed     Text format     Abstract available


  405. BOURGI K, Brar I, Baker-Genaw K
    Health Disparities in Hepatitis C Screening and Linkage to Care at an Integrated Health System in Southeast Michigan.
    PLoS One. 2016;11:e0161241.
    PubMed     Text format     Abstract available


  406. CHEN HJ, Huang N, Chen LS, Chou YJ, et al
    Does Pay-For-Performance Program Increase Providers Adherence to Guidelines for Managing Hepatitis B and Hepatitis C Virus Infection in Taiwan?
    PLoS One. 2016;11:e0161002.
    PubMed     Text format     Abstract available


  407. GOYAL A, Murray JM
    Modelling the Impact of Cell-To-Cell Transmission in Hepatitis B Virus.
    PLoS One. 2016;11:e0161978.
    PubMed     Text format     Abstract available


  408. GARBUGLIA AR, Visco-Comandini U, Lionetti R, Lapa D, et al
    Ultrasensitive HCV RNA Quantification in Antiviral Triple Therapy: New Insight on Viral Clearance Dynamics and Treatment Outcome Predictors.
    PLoS One. 2016;11:e0158989.
    PubMed     Text format     Abstract available


  409. YEH CC, Wang WC, Wu CS, Sung FC, et al
    Association of Sjogrens Syndrome in Patients with Chronic Hepatitis Virus Infection: A Population-Based Analysis.
    PLoS One. 2016;11:e0161958.
    PubMed     Text format     Abstract available


  410. KOROLOWICZ KE, Iyer RP, Czerwinski S, Suresh M, et al
    Antiviral Efficacy and Host Innate Immunity Associated with SB 9200 Treatment in the Woodchuck Model of Chronic Hepatitis B.
    PLoS One. 2016;11:e0161313.
    PubMed     Text format     Abstract available


  411. ZHAO J, Zhong Q, Zhao Y, Hu YX, et al
    Correction: Pathogenicity and Complete Genome Characterization of Fowl Adenoviruses Isolated from Chickens Associated with Inclusion Body Hepatitis and Hydropericardium Syndrome in China.
    PLoS One. 2016;11:e0161744.
    PubMed     Text format     Abstract available


  412. ZHANG Z, Wang G, Kang K, Wu G, et al
    The Diagnostic Accuracy and Clinical Utility of Three Noninvasive Models for Predicting Liver Fibrosis in Patients with HBV Infection.
    PLoS One. 2016;11:e0152757.
    PubMed     Text format     Abstract available


  413. BRADSHAW D, Raghwani J, Jacka B, Sacks-Davis R, et al
    Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual Men.
    PLoS One. 2016;11:e0162002.
    PubMed     Text format     Abstract available


  414. KRAMER B, Finnemann C, Sastre B, Lutz P, et al
    IL-28B Genetic Variants Determine the Extent of Monocyte-Induced Activation of NK Cells in Hepatitis C.
    PLoS One. 2016;11:e0162068.
    PubMed     Text format     Abstract available


  415. ZHANG H, Huo M, Chao J, Liu P, et al
    Application of Bayesian Approach to Cost-Effectiveness Analysis of Antiviral Treatments in Chronic Hepatitis B.
    PLoS One. 2016;11:e0161936.
    PubMed     Text format     Abstract available


  416. ARAUJO OC, Rosa AS, Fernandes A, Niel C, et al
    RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients.
    PLoS One. 2016;11:e0153796.
    PubMed     Text format     Abstract available


  417. CHEN W, Liao B, Hu F, Nie J, et al
    Changing Epidemiology of Hepatitis C Virus Genotype among Patients with Human Immunodeficiency Virus/Hepatitis C Virus Co-Infection in China.
    PLoS One. 2016;11:e0161844.
    PubMed     Text format     Abstract available


  418. BERDEN FA, de Knegt RJ, Blokzijl H, Kuiken SD, et al
    Limited Generalizability of Registration Trials in Hepatitis C: A Nationwide Cohort Study.
    PLoS One. 2016;11:e0161821.
    PubMed     Text format     Abstract available


  419. YANG Y, Ma YP, Chen DP, Zhuo L, et al
    A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous Nephropathy.
    PLoS One. 2016;11:e0160437.
    PubMed     Text format     Abstract available


  420. LIU Y, Zhang S, Zhao Y, Du J, et al
    Development and Application of the Chinese (Mainland) Version of Chronic Liver Disease Questionnaire to Assess the Health-Related Quality of Life (HRQoL) in Patients with Chronic Hepatitis B.
    PLoS One. 2016;11:e0162763.
    PubMed     Text format     Abstract available


  421. POOVORAWAN K, Pan-Ngum W, White LJ, Soonthornworasiri N, et al
    Estimating the Impact of Expanding Treatment Coverage and Allocation Strategies for Chronic Hepatitis C in a Direct Antiviral Agent Era.
    PLoS One. 2016;11:e0163095.
    PubMed     Text format     Abstract available


  422. JUON HS, Strong C, Kim F, Park E, et al
    Lay Health Worker Intervention Improved Compliance with Hepatitis B Vaccination in Asian Americans: Randomized Controlled Trial.
    PLoS One. 2016;11:e0162683.
    PubMed     Text format     Abstract available


  423. LEI Y, Hu T, Song X, Nie H, et al
    Production of Autoantibodies in Chronic Hepatitis B Virus Infection Is Associated with the Augmented Function of Blood CXCR5+CD4+ T Cells.
    PLoS One. 2016;11:e0162241.
    PubMed     Text format     Abstract available


  424. SAMIMI-RAD K, Rahimnia R, Sadeghi M, Malekpour SA, et al
    Epidemic History of Hepatitis C Virus among Patients with Inherited Bleeding Disorders in Iran.
    PLoS One. 2016;11:e0162492.
    PubMed     Text format     Abstract available


  425. WAN Z, Chen Q, Chen X, Duo L, et al
    HCV Diversity among Chinese and Burmese IDUs in Dehong, Yunnan, China.
    PLoS One. 2016;11:e0163062.
    PubMed     Text format     Abstract available


  426. NJOM NLEND AE, Nguwoh PS, Ngounouh CT, Tchidjou HK, et al
    HIV-Infected or -Exposed Children Exhibit Lower Immunogenicity to Hepatitis B Vaccine in Yaounde, Cameroon: An Appeal for Revised Policies in Tropical Settings?
    PLoS One. 2016;11:e0161714.
    PubMed     Text format     Abstract available


  427. PEREIRA-GOMEZ M, Bou JV, Andreu I, Sanjuan R, et al
    Lamivudine/Adefovir Treatment Increases the Rate of Spontaneous Mutation of Hepatitis B Virus in Patients.
    PLoS One. 2016;11:e0163363.
    PubMed     Text format     Abstract available


  428. JIMENEZ-SOUSA MA, Gutierrez-Rivas M, Alvaro-Meca A, Garcia-Alvarez M, et al
    NS3 Resistance-Associated Variants (RAVs) in Patients Infected with HCV Genotype 1a in Spain.
    PLoS One. 2016;11:e0163197.
    PubMed     Text format     Abstract available


  429. IDE T, Eguchi Y, Harada M, Ishii K, et al
    Evaluation of Resistance-Associated Substitutions in NS5A Using Direct Sequence and Cycleave Method and Treatment Outcome with Daclatasvir and Asunaprevir for Chronic Hepatitis C Genotype 1.
    PLoS One. 2016;11:e0163884.
    PubMed     Text format     Abstract available


  430. HASHIMOTO S, Yatsuhashi H, Abiru S, Yamasaki K, et al
    Rapid Increase in Serum Low-Density Lipoprotein Cholesterol Concentration during Hepatitis C Interferon-Free Treatment.
    PLoS One. 2016;11:e0163644.
    PubMed     Text format     Abstract available


  431. NGUYEN LT, Gray E, O'Leary A, Carr M, et al
    The Role of Hepatitis C Virus Core Antigen Testing in the Era of Direct Acting Antiviral Therapies: What We Can Learn from the Protease Inhibitors.
    PLoS One. 2016;11:e0163900.
    PubMed     Text format     Abstract available


  432. VAN SANTEN DK, de Vos AS, Matser A, Willemse SB, et al
    Cost-Effectiveness of Hepatitis C Treatment for People Who Inject Drugs and the Impact of the Type of Epidemic; Extrapolating from Amsterdam, the Netherlands.
    PLoS One. 2016;11:e0163488.
    PubMed     Text format     Abstract available


  433. CAI Q, Chen K, Chen J, Wu S, et al
    The Effect of Prophylactic Lamivudine plus Adefovir Therapy Compared with Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients with High Baseline HBV DNA during Chemotherapy.
    PLoS One. 2016;11:e0164210.
    PubMed     Text format     Abstract available


  434. HUANG C, Lin HH, Wan JB, He C, et al
    Research and Development of Hepatitis B Drugs: An Analysis Based on Technology Flows Measured by Patent Citations.
    PLoS One. 2016;11:e0164328.
    PubMed     Text format     Abstract available


  435. MATSUNAMI K, Nishida N, Kaneko N, Ikeo K, et al
    Genome-Wide Association Study Identifies ZNF354C Variants Associated with Depression from Interferon-Based Therapy for Chronic Hepatitis C.
    PLoS One. 2016;11:e0164418.
    PubMed     Text format     Abstract available


  436. COLLI A, Fraquelli M, Prati D, Riva A, et al
    Deciding on Interferon-Free Treatment for Chronic Hepatitis C: Updating Liver Stiffness Cut-Off Values to Maximize Benefit.
    PLoS One. 2016;11:e0164452.
    PubMed     Text format     Abstract available


  437. GHORI NU, Shafique A, Hayat MQ, Anjum S, et al
    The Phylogeographic and Spatiotemporal Spread of HCV in Pakistani Population.
    PLoS One. 2016;11:e0164265.
    PubMed     Text format     Abstract available


  438. WHITE DA, Anderson ES, Pfeil SK, Deering LJ, et al
    Hepatitis C Virus Screening and Emergency Department Length of Stay.
    PLoS One. 2016;11:e0164831.
    PubMed     Text format     Abstract available


  439. DE AVILA AI, Gallego I, Soria ME, Gregori J, et al
    Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir.
    PLoS One. 2016;11:e0164691.
    PubMed     Text format     Abstract available


  440. YEH CC, Wang WC, Wu CS, Sung FC, et al
    Correction: Association of Sjogren's Syndrome in Patients with Chronic Hepatitis Virus Infection: A Population-Based Analysis.
    PLoS One. 2016;11:e0164911.
    PubMed     Text format     Abstract available


  441. HUANG J, Zhao L, Yang P, Chen Z, et al
    Genome-Wide Transcriptome Analysis of CD36 Overexpression in HepG2.2.15 Cells to Explore Its Regulatory Role in Metabolism and the Hepatitis B Virus Life Cycle.
    PLoS One. 2016;11:e0164787.
    PubMed     Text format     Abstract available


  442. ALRIC L, Besson C, Lapidus N, Jeannel J, et al
    Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.
    PLoS One. 2016;11:e0162965.
    PubMed     Text format     Abstract available


  443. FLISIAK R, Shiffman M, Arenas J, Cheinquer H, et al
    A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C.
    PLoS One. 2016;11:e0164563.
    PubMed     Text format     Abstract available


  444. DAVITKOV P, Chandar AK, Hirsch A, Compan A, et al
    Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C.
    PLoS One. 2016;11:e0163945.
    PubMed     Text format     Abstract available


  445. CHOI YH, Jin N, Kelly F, Sakthivel SK, et al
    Elevation of Alanine Aminotransferase Activity Occurs after Activation of the Cell-Death Signaling Initiated by Pattern-Recognition Receptors but before Activation of Cytolytic Effectors in NK or CD8+ T Cells in the Liver During Acute HCV Infection.
    PLoS One. 2016;11:e0165533.
    PubMed     Text format     Abstract available


  446. SIRAVENHA LG, Siravenha LQ, Madeira LD, Oliveira-Filho AB, et al
    Detection of HCV Persistent Infections in the Dental Pulp: A Novel Approach for the Detection of Past and Ancient Infections.
    PLoS One. 2016;11:e0165272.
    PubMed     Text format     Abstract available


  447. ITAKURA J, Kurosaki M, Hasebe C, Osaki Y, et al
    Complex Pattern of Resistance-Associated Substitutions of Hepatitis C Virus after Daclatasvir/Asunaprevir Treatment Failure.
    PLoS One. 2016;11:e0165339.
    PubMed     Text format     Abstract available


  448. MERAT SJ, Molenkamp R, Wagner K, Koekkoek SM, et al
    Hepatitis C virus Broadly Neutralizing Monoclonal Antibodies Isolated 25 Years after Spontaneous Clearance.
    PLoS One. 2016;11:e0165047.
    PubMed     Text format     Abstract available


  449. KOMATSU H, Inui A, Umetsu S, Tsunoda T, et al
    Evaluation of the G145R Mutant of the Hepatitis B Virus as a Minor Strain in Mother-to-Child Transmission.
    PLoS One. 2016;11:e0165674.
    PubMed     Text format     Abstract available


  450. ZHANG Y, Cao Y, Zhang R, Zhang X, et al
    Pre-Existing HCV Variants Resistant to DAAs and Their Sensitivity to PegIFN/RBV in Chinese HCV Genotype 1b Patients.
    PLoS One. 2016;11:e0165658.
    PubMed     Text format     Abstract available


  451. LIN MT, Yen YH, Tsai MC, Tseng PL, et al
    Comparison of the Efficacies and Safety of Combined Therapy between Telbivudine Plus Adefovir and Lamivudine Plus Adefovir in Patients with Hepatitis B Virus Infection in Real-World Practice.
    PLoS One. 2016;11:e0165416.
    PubMed     Text format     Abstract available


  452. LEE D, Park SM
    Cost-Effectiveness Analysis of Hepatitis B Vaccination Strategies to Prevent Perinatal Transmission in North Korea: Selective Vaccination vs. Universal Vaccination.
    PLoS One. 2016;11:e0165879.
    PubMed     Text format     Abstract available


  453. LOFTFIELD E, O'Brien TR, Pfeiffer RM, Howell CD, et al
    Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials.
    PLoS One. 2016;11:e0166036.
    PubMed     Text format     Abstract available


  454. SU FH, Wu CS, Sung FC, Chang SN, et al
    Correction: Chronic Hepatitis C Virus Infection Is Associated with the Development of Rheumatoid Arthritis: A Nationwide Population-Based Study in Taiwan.
    PLoS One. 2016;11:e0166508.
    PubMed     Text format     Abstract available


  455. STENE-JOHANSEN K, Yaqoob N, Overbo J, Aberra H, et al
    Dry Blood Spots a Reliable Method for Measurement of Hepatitis B Viral Load in Resource-Limited Settings.
    PLoS One. 2016;11:e0166201.
    PubMed     Text format     Abstract available


  456. MIDGARD H, Bramness JG, Skurtveit S, Haukeland JW, et al
    Hepatitis C Treatment Uptake among Patients Who Have Received Opioid Substitution Treatment: A Population-Based Study.
    PLoS One. 2016;11:e0166451.
    PubMed     Text format     Abstract available


  457. PALMER BA, Fanning LJ
    Synonymous Co-Variation across the E1/E2 Gene Junction of Hepatitis C Virus Defines Virion Fitness.
    PLoS One. 2016;11:e0167089.
    PubMed     Text format     Abstract available


  458. LEE KY, Chen YH, Hsu SC, Yu MJ, et al
    Phosphorylation of Serine 235 of the Hepatitis C Virus Non-Structural Protein NS5A by Multiple Kinases.
    PLoS One. 2016;11:e0166763.
    PubMed     Text format     Abstract available


  459. AIKEN T, Garber A, Thomas D, Hamon N, et al
    Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C.
    PLoS One. 2016;11:e0166998.
    PubMed     Text format     Abstract available


  460. CHANG ML, Kuo CJ, Huang HC, Chu YY, et al
    Association between Leptin and Complement in Hepatitis C Patients with Viral Clearance: Homeostasis of Metabolism and Immunity.
    PLoS One. 2016;11:e0166712.
    PubMed     Text format     Abstract available


  461. GAMBATO M, Caro-Perez N, Gonzalez P, Canete N, et al
    Neutrophil and Monocyte Function in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy with Regimens Containing Protease Inhibitors with and without Interferon.
    PLoS One. 2016;11:e0166631.
    PubMed     Text format     Abstract available


  462. LEE M, Kim W, Choi Y, Kim S, et al
    Correction: Spontaneous Evolution in Bilirubin Levels Predicts Liver-Related Mortality in Patients with Alcoholic Hepatitis.
    PLoS One. 2016;11:e0167184.
    PubMed     Text format     Abstract available


  463. UMARE A, Seyoum B, Gobena T, Haile Mariyam T, et al
    Hepatitis B Virus Infections and Associated Factors among Pregnant Women Attending Antenatal Care Clinic at Deder Hospital, Eastern Ethiopia.
    PLoS One. 2016;11:e0166936.
    PubMed     Text format     Abstract available


  464. HAMAD HA, Thurston J, Teague T, Ackad E, et al
    The NS4A Cofactor Dependent Enhancement of HCV NS3 Protease Activity Correlates with a 4D Geometrical Measure of the Catalytic Triad Region.
    PLoS One. 2016;11:e0168002.
    PubMed     Text format     Abstract available


  465. JEON I, Cho ES, Kim JH, Kim DJ, et al
    Feasibility of 10-Minute Delayed Hepatocyte Phase Imaging Using a 30 degrees Flip Angle in Gd-EOB-DTPA-Enhanced Liver MRI for the Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis or Cirrhosis.
    PLoS One. 2016;11:e0167701.
    PubMed     Text format     Abstract available


  466. CHIEN TL, Wang JH, Kee KM, Chen CH, et al
    Factors Predicting HBsAg Seroclearance and Alanine Transaminase Elevation in HBeAg-Negative Hepatitis B Virus-Infected Patients with Persistently Normal Liver Function.
    PLoS One. 2016;11:e0166543.
    PubMed     Text format     Abstract available


  467. PUIGVEHI M, Hernandez J, Broquetas T, Coll S, et al
    Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF(R)) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 Years.
    PLoS One. 2016;11:e0164883.
    PubMed     Text format     Abstract available


  468. VIARD JP, Assuied A, Levy Y, Souberbielle JC, et al
    No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults.
    PLoS One. 2016;11:e0168640.
    PubMed     Text format     Abstract available


  469. NUNEZ-TORRES R, Macias J, Mancebo M, Frias M, et al
    The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.
    PLoS One. 2016;11:e0168265.
    PubMed     Text format     Abstract available


  470. SARRAZIN C, Manns M, Calleja JL, Garcia-Samaniego J, et al
    HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment.
    PLoS One. 2016;11:e0168544.
    PubMed     Text format     Abstract available


  471. EL-GHITANY EM, Farghaly AG, Farag S, Abd El-Wahab EW, et al
    Validation of EGCRISC for Chronic Hepatitis C Infection Screening and Risk Assessment in the Egyptian Population.
    PLoS One. 2016;11:e0168649.
    PubMed     Text format     Abstract available


  472. VILLANI R, Facciorusso A, Bellanti F, Tamborra R, et al
    DAAs Rapidly Reduce Inflammation but Increase Serum VEGF Level: A Rationale for Tumor Risk during Anti-HCV Treatment.
    PLoS One. 2016;11:e0167934.
    PubMed     Text format     Abstract available


  473. CHUNG JW, Kim BH, Lee CS, Kim GH, et al
    Optimizing Surveillance Performance of Alpha-Fetoprotein by Selection of Proper Target Population in Chronic Hepatitis B.
    PLoS One. 2016;11:e0168189.
    PubMed     Text format     Abstract available


  474. HUANG YS, Chang SY, Sheng WH, Sun HY, et al
    Virological Response to Tenofovir Disoproxil Fumarate in HIV-Positive Patients with Lamivudine-Resistant Hepatitis B Virus Coinfection in an Area Hyperendemic for Hepatitis B Virus Infection.
    PLoS One. 2016;11:e0169228.
    PubMed     Text format     Abstract available


  475. YASUI Y, Abe T, Kurosaki M, Higuchi M, et al
    Elastin Fiber Accumulation in Liver Correlates with the Development of Hepatocellular Carcinoma.
    PLoS One. 2016;11:e0154558.
    PubMed     Text format     Abstract available


  476. BOCHAROV G, Meyerhans A, Bessonov N, Trofimchuk S, et al
    Spatiotemporal Dynamics of Virus Infection Spreading in Tissues.
    PLoS One. 2016;11:e0168576.
    PubMed     Text format     Abstract available


  477. DE MIGUEL-DIEZ J, Lopez-de-Andres A, Jimenez-Garcia R, Puente-Maestu L, et al
    Trends in Epidemiology of COPD in HIV-Infected Patients in Spain (1997-2012).
    PLoS One. 2016;11:e0166421.
    PubMed     Text format     Abstract available


  478. NJOKU OS, Manak MM, O'Connell RJ, Shutt AL, et al
    An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria.
    PLoS One. 2016;11:e0166711.
    PubMed     Text format     Abstract available


  479. LIMA K, de Souza Leal E, Cavalcanti AM, Salustiano DM, et al
    Epidemiological, Clinical and Antiretroviral Susceptibility Characterization of Human Immunodeficiency Virus Subtypes B and Non-B in Pernambuco, Northeast Brazil.
    PLoS One. 2016;11:e0155854.
    PubMed     Text format     Abstract available


  480. BRUDER COSTA J, Dufeu-Duchesne T, Leroy V, Bertucci I, et al
    Pegylated Interferon alpha-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion.
    PLoS One. 2016;11:e0158297.
    PubMed     Text format     Abstract available


  481. PLAISTED WC, Zavala A, Hingco E, Tran H, et al
    Remyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple Sclerosis.
    PLoS One. 2016;11:e0157620.
    PubMed     Text format     Abstract available


  482. FARSHADPOUR F, Taherkhani R, Tajbakhsh S, Gholizadeh Tangestani M, et al
    Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study.
    PLoS One. 2016;11:e0157615.
    PubMed     Text format     Abstract available


  483. WU H, Padhi A, Xu J, Gong X, et al
    Evidence for Within-Host Genetic Recombination among the Human Pegiviral Strains in HIV Infected Subjects.
    PLoS One. 2016;11:e0161880.
    PubMed     Text format     Abstract available


  484. O'DONNELL PE, Ye XZ, DeChellis MA, Davis VM, et al
    Lipodystrophy, Diabetes and Normal Serum Insulin in PPARgamma-Deficient Neonatal Mice.
    PLoS One. 2016;11:e0160636.
    PubMed     Text format     Abstract available


  485. REMIS RS, Liu J, Loutfy MR, Tharao W, et al
    Prevalence of Sexually Transmitted Viral and Bacterial Infections in HIV-Positive and HIV-Negative Men Who Have Sex with Men in Toronto.
    PLoS One. 2016;11:e0158090.
    PubMed     Text format     Abstract available


    January 2015
  486. MIGITA K, Komori A, Kozuru H, Jiuchi Y, et al
    Circulating microRNA Profiles in Patients with Type-1 Autoimmune Hepatitis.
    PLoS One. 2015;10:e0136908.
    PubMed     Text format     Abstract available


  487. SARKAR N, Pal A, Das D, Saha D, et al
    Virological Characteristics of Acute Hepatitis B in Eastern India: Critical Differences with Chronic Infection.
    PLoS One. 2015;10:e0141741.
    PubMed     Text format     Abstract available


  488. FOUQUET B, Ghosn J, Quertainmont Y, Salmon D, et al
    Identification of Variants of Hepatitis C Virus (HCV) Entry Factors in Patients Highly Exposed to HCV but Remaining Uninfected: An ANRS Case-Control Study.
    PLoS One. 2015;10:e0142698.
    PubMed     Text format     Abstract available



  489. Correction: Development of Self-Management Indicators for Chronic Hepatitis B Patients on Antiviral Therapy: Results of a Chinese Delphi Panel Survey.
    PLoS One. 2015;10:e0143464.
    PubMed     Text format     Abstract available


  490. AMANZADA A, Reinhardt L, Fey D, Zeisberg EM, et al
    Hepatic Interferon-lambda3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C.
    PLoS One. 2015;10:e0143783.
    PubMed     Text format     Abstract available


  491. ZHANG X, Zhai L, Rong C, Qin X, et al
    Association of Ghrelin Gene Polymorphisms and Serum Ghrelin Levels with the Risk of Hepatitis B Virus-Related Liver Diseases in a Chinese Population.
    PLoS One. 2015;10:e0143069.
    PubMed     Text format     Abstract available


  492. SCHEINER B, Mandorfer M, Schwabl P, Payer BA, et al
    The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection.
    PLoS One. 2015;10:e0143429.
    PubMed     Text format     Abstract available


  493. AN HAACK I, Derkow K, Riehn M, Rentinck MN, et al
    The Role of Regulatory CD4 T Cells in Maintaining Tolerance in a Mouse Model of Autoimmune Hepatitis.
    PLoS One. 2015;10:e0143715.
    PubMed     Text format     Abstract available


  494. HE YF, Wang CQ, Yu Y, Qian J, et al
    Tie2-Expressing Monocytes Are Associated with Identification and Prognoses of Hepatitis B Virus Related Hepatocellular Carcinoma after Resection.
    PLoS One. 2015;10:e0143657.
    PubMed     Text format     Abstract available


  495. WANG ZS, Guo WD, Wu LQ, Yi X, et al
    Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration.
    PLoS One. 2015;10:e0142727.
    PubMed     Text format     Abstract available


  496. LIMA VD, Rozada I, Grebely J, Hull M, et al
    Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?
    PLoS One. 2015;10:e0143836.
    PubMed     Text format     Abstract available


  497. GREENAWAY C, Ma AT, Kloda LA, Klein M, et al
    Correction: The Seroprevalence of Hepatitis C Antibodies in Immigrants and Refugees from Intermediate and High Endemic Countries: A Systematic Review and Meta-Analysis.
    PLoS One. 2015;10:e0144567.
    PubMed     Text format     Abstract available


  498. ASSELAH T, Zeuzem S, Soriano V, Bronowicki JP, et al
    ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection.
    PLoS One. 2015;10:e0144004.
    PubMed     Text format     Abstract available


  499. REYES-AVILES E, Kostadinova L, Rusterholtz A, Cruz-Lebron A, et al
    Presence of Rheumatoid Factor during Chronic HCV Infection Is Associated with Expansion of Mature Activated Memory B-Cells that Are Hypo-Responsive to B-Cell Receptor Stimulation and Persist during the Early Stage of IFN Free Therapy.
    PLoS One. 2015;10:e0144629.
    PubMed     Text format     Abstract available


  500. MACIAS J, Lopez-Cortes LF, Tellez F, Recio E, et al
    Low Efficacy of Pegylated Interferon plus Ribavirin plus Nitazoxanide for HCV Genotype 4 and HIV Coinfection.
    PLoS One. 2015;10:e0143492.
    PubMed     Text format     Abstract available


  501. MUSSINI C, Lorenzini P, Puoti M, Lichtner M, et al
    Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.
    PLoS One. 2015;10:e0140877.
    PubMed     Text format     Abstract available


  502. ABOUT F, Oudot-Mellakh T, Niay J, Rabiega P, et al
    Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study.
    PLoS One. 2015;10:e0145105.
    PubMed     Text format     Abstract available


  503. YOKOYAMA Y, Miyagi T, Hikita H, Yoshioka T, et al
    The Hepatitis B Virus Genotype Affects the Persistence of Viral Replication in Immunodeficient NOG Mice.
    PLoS One. 2015;10:e0144775.
    PubMed     Text format     Abstract available


  504. ABOULNASR F, Hazari S, Nayak S, Chandra PK, et al
    IFN-lambda Inhibits MiR-122 Transcription through a Stat3-HNF4alpha Inflammatory Feedback Loop in an IFN-alpha Resistant HCV Cell Culture System.
    PLoS One. 2015;10:e0141655.
    PubMed     Text format     Abstract available


  505. PAULSEN D, Weber O, Ruebsamen-Schaeff H, Tennant BC, et al
    AIC649 Induces a Bi-Phasic Treatment Response in the Woodchuck Model of Chronic Hepatitis B.
    PLoS One. 2015;10:e0144383.
    PubMed     Text format     Abstract available


  506. BINKA M, Paintsil E, Patel A, Lindenbach BD, et al
    Correction: Survival of Hepatitis C Virus in Syringes Is Dependent on the Design of the Syringe-Needle and Dead Space Volume.
    PLoS One. 2015;10:e0146088.
    PubMed     Text format     Abstract available


  507. CHENG X, Guan W, Sun S, Li B, et al
    Stable Human Hepatoma Cell Lines for Efficient Regulated Expression of Nucleoside/Nucleotide Analog Resistant and Vaccine Escape Hepatitis B Virus Variants and Woolly Monkey Hepatitis B Virus.
    PLoS One. 2015;10:e0145746.
    PubMed     Text format     Abstract available


  508. WIEGAND SB, Heidrich B, Susser S, Rogalska-Taranta M, et al
    Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.
    PLoS One. 2015;10:e0145622.
    PubMed     Text format     Abstract available


  509. AHN JM, Sinn DH, Gwak GY, Paik YH, et al
    Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels.
    PLoS One. 2015;10:e0144777.
    PubMed     Text format     Abstract available


  510. VIRINE B, Osiowy C, Gao S, Wang T, et al
    Correction: Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients During Pregnancy and Post-Partum Follow-up.
    PLoS One. 2015;10:e0145898.
    PubMed     Text format     Abstract available


  511. AMADO LEON LA, de Almeida AJ, de Paula VS, Tourinho RS, et al
    Longitudinal Study of Hepatitis A Infection by Saliva Sampling: The Kinetics of HAV Markers in Saliva Revealed the Application of Saliva Tests for Hepatitis A Study.
    PLoS One. 2015;10:e0145454.
    PubMed     Text format     Abstract available


  512. GEUE C, Wu O, Xin Y, Heggie R, et al
    Cost-Effectiveness of HBV and HCV Screening Strategies - A Systematic Review of Existing Modelling Techniques.
    PLoS One. 2015;10:e0145022.
    PubMed     Text format     Abstract available


  513. FORBI JC, Layden JE, Phillips RO, Mora N, et al
    Next-Generation Sequencing Reveals Frequent Opportunities for Exposure to Hepatitis C Virus in Ghana.
    PLoS One. 2015;10:e0145530.
    PubMed     Text format     Abstract available


  514. SUWANTHAWORNKUL T, Anothaisintawee T, Sobhonslidsuk A, Thakkinstian A, et al
    Efficacy of Second Generation Direct-Acting Antiviral Agents for Treatment Naive Hepatitis C Genotype 1: A Systematic Review and Network Meta-Analysis.
    PLoS One. 2015;10:e0145953.
    PubMed     Text format     Abstract available


  515. GRAUMANN F, Churin Y, Tschuschner A, Reifenberg K, et al
    Genomic Methylation Inhibits Expression of Hepatitis B Virus Envelope Protein in Transgenic Mice: A Non-Infectious Mouse Model to Study Silencing of HBV Surface Antigen Genes.
    PLoS One. 2015;10:e0146099.
    PubMed     Text format     Abstract available


  516. DASSAH S, Sakyi SA, Frempong MT, Luuse AT, et al
    Seroconversion of Hepatitis B Vaccine in Young Children in the Kassena Nankana District of Ghana: A Cross-Sectional Study.
    PLoS One. 2015;10:e0145209.
    PubMed     Text format     Abstract available


  517. CABALLERO A, Gregori J, Homs M, Tabernero D, et al
    Complex Genotype Mixtures Analyzed by Deep Sequencing in Two Different Regions of Hepatitis B Virus.
    PLoS One. 2015;10:e0144816.
    PubMed     Text format     Abstract available


  518. ZHANG YY
    Duck Hepatitis B Virus cccDNA Amplification Efficiency in Natural Infection Is Regulated by Virus Secretion Efficiency.
    PLoS One. 2015;10:e0145465.
    PubMed     Text format     Abstract available


  519. CHENG J, Hou J, Ding H, Chen G, et al
    Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B.
    PLoS One. 2015;10:e0144425.
    PubMed     Text format     Abstract available


  520. SCHARTON D, Van Wettere AJ, Bailey KW, Vest Z, et al
    Rift Valley fever virus infection in golden Syrian hamsters.
    PLoS One. 2015;10:e0116722.
    PubMed     Text format     Abstract available


  521. RYCROFT D, Sosabowski J, Coulstock E, Davies M, et al
    Pharmacokinetic characteristics, pharmacodynamic effect and in vivo antiviral efficacy of liver-targeted interferon alpha.
    PLoS One. 2015;10:e0117847.
    PubMed     Text format     Abstract available


  522. JIA Y, Zeng Z, Li Y, Li Z, et al
    Impaired function of CD4+ T follicular helper (Tfh) cells associated with hepatocellular carcinoma progression.
    PLoS One. 2015;10:e0117458.
    PubMed     Text format     Abstract available


  523. DENG Y, Xie M, Xie L, Wang J, et al
    Association between polymorphism of the interleukin-13 gene and susceptibility to hepatocellular carcinoma in the Chinese population.
    PLoS One. 2015;10:e0116682.
    PubMed     Text format     Abstract available


  524. DE MONTEYNARD LA, Dray-Spira R, de Truchis P, Grabar S, et al
    Later cART Initiation in Migrant Men from Sub-Saharan Africa without Advanced HIV Disease in France.
    PLoS One. 2015;10:e0118492.
    PubMed     Text format     Abstract available


  525. YU D, Zhang G, Huang X, Wu C, et al
    Relatively Small Contribution of Methylation and Genomic Copy Number Aberration to the Aberrant Expression of Inflammation-Related Genes in HBV-Related Hepatocellular Carcinoma.
    PLoS One. 2015;10:e0126836.
    PubMed     Text format     Abstract available


  526. SINN DH, Cho JY, Gwak GY, Paik YH, et al
    Different survival of Barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spread.
    PLoS One. 2015;10:e0124434.
    PubMed     Text format     Abstract available


  527. NEUMANN K, Erben U, Kruse N, Wechsung K, et al
    Chemokine Transfer by Liver Sinusoidal Endothelial Cells Contributes to the Recruitment of CD4+ T Cells into the Murine Liver.
    PLoS One. 2015;10:e0123867.
    PubMed     Text format     Abstract available


  528. GUO W, Zhang W, Liu C, Song Y, et al
    Clinical Analysis of the HBV Infection Status of 135 Patients with Diffuse Large B Cell Lymphoma Treated with R-CHOP or CHOP/CHOP-Like Chemotherapy.
    PLoS One. 2015;10:e0129064.
    PubMed     Text format     Abstract available


  529. LIU X, Chi X, Gong Q, Gao L, et al
    Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    PLoS One. 2015;10:e0127518.
    PubMed     Text format     Abstract available


  530. AMORAS EDA S, Gomes ST, Freitas FB, Santana BB, et al
    NGF and P75NTR gene expression is associated with the hepatic fibrosis stage due to viral and non-viral causes.
    PLoS One. 2015;10:e0121754.
    PubMed     Text format     Abstract available


  531. HUANG Y, Deng H, Shan X, Gong X, et al
    Lower mutation frequency of BCP/precore regions in e antigen-negative chronic HBV-infected children instead of adults patients.
    PLoS One. 2015;10:e0120733.
    PubMed     Text format     Abstract available


  532. LIN CK, Hung CC, Peng CY, Chao E, et al
    Factors Associated with Methadone Treatment Duration: A Cox Regression Analysis.
    PLoS One. 2015;10:e0123687.
    PubMed     Text format     Abstract available


  533. YIN J, Wen J, Hang D, Han J, et al
    Expression Quantitative Trait Loci for CARD8 Contributes to Risk of Two Infection-Related Cancers-Hepatocellular Carcinoma and Cervical Cancer.
    PLoS One. 2015;10:e0132352.
    PubMed     Text format     Abstract available


  534. THAKARAR K, Morgan JR, Gaeta JM, Hohl C, et al
    Predictors of Frequent Emergency Room Visits among a Homeless Population.
    PLoS One. 2015;10:e0124552.
    PubMed     Text format     Abstract available


  535. OCHIENG C, Ahenda P, Vittor AY, Nyoka R, et al
    Seroprevalence of Infections with Dengue, Rift Valley Fever and Chikungunya Viruses in Kenya, 2007.
    PLoS One. 2015;10:e0132645.
    PubMed     Text format     Abstract available


  536. HEIDRICH B, Cordes HJ, Klinker H, Moller B, et al
    Treatment Extension of Pegylated Interferon Alpha and Ribavirin Does Not Improve SVR in Patients with Genotypes 2/3 without Rapid Virological Response (OPTEX Trial): A Prospective, Randomized, Two-Arm, Multicentre Phase IV Clinical Trial.
    PLoS One. 2015;10:e0128069.
    PubMed     Text format     Abstract available


  537. GU L, Han Y, Li Y, Zhu T, et al
    Emergence of Lamivudine-Resistant HBV during Antiretroviral Therapy Including Lamivudine for Patients Coinfected with HIV and HBV in China.
    PLoS One. 2015;10:e0134539.
    PubMed     Text format     Abstract available


  538. SCOTT N, McBryde E, Kirwan A, Stoove M, et al
    Modelling the Impact of Condom Distribution on the Incidence and Prevalence of Sexually Transmitted Infections in an Adult Male Prison System.
    PLoS One. 2015;10:e0144869.
    PubMed     Text format     Abstract available


    January 2014
  539. HUANG X, Tan H, Li X, Zhou S, et al
    Maternal chronic HBV infection would not increase the risk of pregnancy-induced hypertension - results from pregnancy cohort in liuyang rural china.
    PLoS One. 2014;9:e114248.
    PubMed     Text format     Abstract available


  540. ABDEL-MOHSEN M, Deng X, Danesh A, Liegler T, et al
    Role of MicroRNA Modulation in the Interferon-alpha/Ribavirin Suppression of HIV-1 In Vivo.
    PLoS One. 2014;9:e109220.
    PubMed     Text format     Abstract available


  541. BORGES AH, O'Connor JL, Phillips AN, Baker JV, et al
    Factors Associated with D-Dimer Levels in HIV-Infected Individuals.
    PLoS One. 2014;9:e90978.
    PubMed     Text format     Abstract available


  542. KATO N, Sejima H, Ueda Y, Mori K, et al
    Genetic characterization of hepatitis C virus in long-term RNA replication using li23 cell culture systems.
    PLoS One. 2014;9:e91156.
    PubMed     Text format     Abstract available


  543. HWANG KK, Trama AM, Kozink DM, Chen X, et al
    IGHV1-69 B Cell Chronic Lymphocytic Leukemia Antibodies Cross-React with HIV-1 and Hepatitis C Virus Antigens as Well as Intestinal Commensal Bacteria.
    PLoS One. 2014;9:e90725.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: